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GENERAL INTRODUCTION 
Cells are exposed to oxidative insult throughout the life span of an organism. 
Cellular respiration relies on single electron reductions of molecular oxygen to water in order 
to produce energy, so that intermediate reactive oxygen species are continually being 
generated by mitochondria. Some of these reactive intermediates inevitably escape into the 
cytoplasm, causing a steady flux of reactive oxygen species within ceils. Inunune cells 
generate hydrogen peroxide, superoxide, nitric oxide and peroxynitrite when activated as part 
of host defense in higher organisms. Cancer cells have been shown to produce hydrogen 
peroxide at levels equivalent to the oxidative burst of neutrophils (1). Several disease states 
including cancer (1,2), immune disorders (3), neurodegenerative disorders (4) and aging (5) 
are accompanied by oxidative phenomena. Within cells, proteins are susceptible to damage 
in these oxidative conditions (5). Cysteine, because of its reactive sulfhydryl-containing 
sidechain, is particularly susceptible to oxidative modification (6). Modification of cysteine 
residues of proteins has been shown to occur within cells under diverse oxidative conditions 
(7-11), and has been shown to inhibit the activity of puriHed proteins (12,13,14). Oxidation 
of protein cysteine residues thus has the potential of permanently inactivating proteins and 
disrupting their normal functions. 
Glutathione function in cells 
Organisms have evolved mechanisms for eliminating excess reactive oxygen species. 
This includes enzymatic systems such as superoxide dismutase, catalase, and glutathione 
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peroxidase. Low molecular weight antioxidants, such as ascorbate, vitamin E and 
glutathione (GSH)'"^ act as scavengers alone or as a part of enzymatic systems. The 
tripeptide GSH is able to protect cells from oxidative insult, although the mechanism for this 
protection is not completely understood. It is proposed that GSH acts as a reductant of 
reactive oxygen species (ROS) either on its own (15-18) or in conjunction with glutathione 
peroxidase, reducing the oxidant and in the process being converted to glutathione disulfide 
(GSSG): 
[1] GSH + ROSox -» GSSG + ROSred 
GSSG can be reduced back to GSH by glutathione reductase at the expense of cellular 
NADPH: 
Glutathione Reductase 
[2] GSSG + NADPH > 2GSH + NADP^ + 2H^ 
Protein S-glutathioIation 
GSH may also act in concert with reactive cysteine residues on proteins to protect 
these same residues from oxidative damage (6,7,19): 
' Abbreviations used in this dissertation: AAPH, 2,2'-azobis(2-amidinopropane)dihydrochloride; 
DTT, dithiothreitol; Erk, extracellular signal-regulated kinase; GSH, reduced glutathione; GSSG, glutathione 
disulfide; lAA, iodoacetic acid; lAM, iodoacetamide; lEF, isoelectric focusing; MEK, Mitogen activated 
protein kinase/Erk kinase; MEM, N-ethylmaleimide; ROS, reactive oxygen species. 
^ A note on nomenclature: GSH refers ONLY to the reduced form of glutathione. GSSG refers only to 
glutathione disulflde. Oxidized glutathione may refer to several forms of glutathione including GSSG, cysteine-
glutathione disulfide, S-glutathiolated protein and S-nitrosoglutathione. 
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[3] GSH + ProteinSH + ROSox —> ProteinSSG + ROSred 
Protein cysteines can be S-giutathiolated in cells by a variety of oxidants including 
activated neutrophils, monocytes, H2O2, superoxide, t-butyl hydroperoxide, menadione, and 
diamide (7-10,19). Several proteins that are readily S-glutathiolated in cells include carbonic 
anhydrase III (20), actin (8), hemoglobin (21), and glyceraldehyde-3-phosphate 
dehydrogenase (9). A role for protein thiols in protection of cells from oxidative damage has 
been proposed (6,21,22,23), but reaction rates of protein thiols with oxidants such as H2O2 or 
superoxide might not be sufficiently fast to compete with other antioxidant systems to make a 
significant contribution (24). In cells, protein S-glutathiolation is a transient event. 
However, the mechanism for the reduction of S-glutathiolated proteins is not well 
characterized. The protein-glutathione mixed disulfide, known as an S-glutathiolated 
protein, could be converted back to the reduced protein by another molecule of GSH (20,25); 
[4] ProteinSSG + GSH ProteinSH + GSSG 
Cellular dithiol proteins such as glutaredoxin or thioredoxin (25) could also reduce 
the S-glutathiolated protein: 
[5] ProteinSSG + Protein(SH)2 —> ProteinSH + Protein(SSG)SH 
GSSG would then be reduced as in equation 2, while the dithiol protein could be 
reduced as in equation 4 or undergo internal thiol-disulfide exchange: 
[6] Pr(SSG)SH -> PrS2 + GSH 
The oxidized disulfide protein product of equation 6 could be reduced by other dithiol 
proteins, or be reduced by a dithiol reductase like thioredoxin reductase. The appearance of 
S-glutathiolated proteins in cells under oxidative stress (7-10,19) and the identification of 
glutaredoxin as a specific dethiolase capable of reducing protein-glutathione mixed disulfides 
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(25), suggest that the interaction of GSH with proteins is a significant antioxidant function of 
GSH in cells. 
Irreversible oxidation of protein cysteine 
The cytosolic protein, carbonic anhydrase EH, has been shown to be S-glutathiolated 
in vivo by oxidants including diamide, t-butyl hydroperoxide, menadione, H2O2, and 
superoxide (7,19,25). Additionally, purified carbonic anhydrase III is S-glutathiolated by 
H2O2, diamide, GSSG, and superoxide (7,19,20). In conditions of GSH depletion in cells, 
menadione has been shown to cause irreversible oxidation, i.e., oxidation of cysteine to a 
state that is not reducible by thiol-disulfide exchange, of carbonic anhydrase III (7). 
Xanthine/xanthine oxidase can cause irreversible oxidation of purified carbonic anhydrase III 
when GSH is not present to protect protein cysteines (19). Thus, in the absence of GSH, the 
reaction of protein with an oxidant does not proceed as in equation 3, but rather as in 
equation 7: 
[7] ProteinSH + ROSox -> ProteinSo* + ROSreu 
This oxidized form of protein could not be reduced by equations 4-6 but instead 
would permanently lose the function of the cysteine residue. If this cysteine were part of the 
catalytic center of a protein, then the protein would be rendered inactive. These irreversible 
oxidation products have not been very well characterized. Based upon studies of oxidation 
of low molecular weight thiols, it is likely that these oxidation products are cysteine sulfinic 
or cysteine sulfonic acid (15). Reactions of purified monoalkylated glutathione reductase 
with H202 have been shown to produce cysteine sulfonic acid (13). Sulfinic acid formed in 
the active site of purified glutathione reductase that was incubated with dinitrosyl-
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diglutathionyl-iron as determined by X-ray crystallography (26). Similarly, sulfinic and 
sulfonic acid have been found at the active site of NADH peroxidase (27). These 
experiments demonstrate the formation of irreversibly oxidized protein cysteine residues. 
Developing an assay for irreversibly oxidized cysteine may be a critical step in understanding 
the interactions between GSH and protein cysteines. 
Oxidative regulation of signal transduction 
Oxidation may play an important role in the degeneration and loss of control of signal 
transduction pathways that is associated with aging, cancer, and other disease states 
(1,2,5,28-30). It is well known that nitric oxide (NO) regulates vascular relaxation through 
initial stimulation of guanylate cyclase by NO (31). This produces cyclic guanosine 
monophosphate (cGMP), which interacts with signaling pathways to produce the vascular 
relaxation. However, NO plays multiple roles in cells, including direct oxidation of proteins 
and glutathione (32,33), For example, NO can prevent apoptosis through direct modification 
of the active site cysteine of caspase-3 (32). NO and other reactive oxygen species may also 
contribute to tyrosine phosphorylation of proteins in cell by inhibiting tyrosine phosphatases 
(14,34,35). 
The role of reactive oxygen species in signal transduction may not be limited to 
inhibition of protein activity. For instance, stress-inducible transcription is activated by 
oxidative modification of OxyR, NF-KB, and AP-1 (36-38). Apoptosis appears to be 
inhibited by H2O2 soon after treatment of cells through direct inhibition of caspase-3 (39). 
However, if the initial dose of H2O2 is above a threshold level, apoptosis may be initiated at a 
later time (39). Thus, the role of H2O2 in apoptosis is complex and depends on more than 
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simple inhibition of caspase-3. 3-Morpholinosydnonimine (SIN-1), a compound that 
generates superoxide and nitric oxide appears to regulate the lipidation of proteins in 
neuronal cell lines (40). This suggests that reactive oxygen species may also regulate 
proteins through subcellular localization of proteins to cellular membranes. 
Ras 
Ras is a guanine nucleotide binding protein that is essential for proliferation and 
differentiation in many eukaryotic cell types (41). Ras is an intermediate in the well-
characterized extracellular signal-regulated kinase (Erk) pathway, a signal transduction 
cascade which begins at a membrane bound receptor and ends in the nucleus (41,42). 
Binding OTP (43) activates Ras. This binding occurs very slowly because it requires the 
release of GDP, which inactivates Ras. However, when effectors upstream of Ras are 
activated, guanine nucleotide exchange factors (GEFs) stimulate Ras to release GDP and 
bind GTP (44,4S). This activated Ras then will bind and activate Raf, which can 
phosphorylate and activate MAP kinase/ERK kinase (MEK). MEK phosphorylates and 
activates the Erks, which translocate into the nucleus and activate transcription of genes. 
When Ras hydrolyzes GTP to GDP (46), it becomes inactive once again. Because the 
endogenous GTPase activity of Ras is very low, GTPase activating proteins (GAPs) are 
necessary for inactivation of Ras by stimulating its GTPase activity (44,45). 
Ras mutants that are unable to hydrolyze GTP, or are otherwise unable to become 
inactive, are oncogenic, causing uncontrolled proliferation of cells. Activated forms of Ras 
are found in >30% of all human cancers (44). While Ras is central to the Erk pathway. 
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interactions with many (liferent signal transduction cascades seem to be a necessary part of 
the cellular function of Ras (41). 
H-Ras 
Ras proteins exhibit a high degree of homology over much of the protein, but vary 
significantly near the C-terminus. The C-terminus of H-Ras, one of 4 closely related Ras 
family members, contains three cysteine residues that impart unique biochemical properties 
that are not entirely understood on the biological level (47,48). One cysteine, Cysl86. is 
famesylated, while the other two C-terminal cysteines, Cysl81 and Cysl84, are 
palmitoylated in vivo. Famesylation is the addition of a Cis isoprenoid to the cysteine via a 
thioether linkage. Famesylation is catalyzed by a famesyi transferase that specifically 
recognizes a four amino acid motif that occurs at the C-terminus of H-Ras (i.e. CaaX). 
Famesylation is thought to localize H-Ras to the plasma membrane and may also play a role 
in further localization within that membrane (47). H-Ras loses its biological activity if 
famesylation is prevented (49-52). Palmitoylation of Cysl81 and Cysl84 is a reversible 
modification via a thioester linkage. Membrane localization is possible without 
palmitoylation, but biological activity and the ability of oncogenic mutants of H-Ras to cause 
transformation is reversed when one or both of these cysteines is mutated (48). No enzymes 
that catalyze palmitoylation or depalmitoylation of H-Ras have been found to date. The 
biological function of palmitoylation is still uncertain. 
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Oxidative modulation of the Erk pathway 
X-irradiation, H2O2, superoxide, NO, S-nitroso-N-acetylpenicillamine, and sodium 
nitroprusside have all been found to promote activation the Erk pathway in cell culture 
systems (52-55). The degree of activation and the kinetics of this activation appear to depend 
on the source and dose of the reactive oxygen species applied (53,54). Erk activity is 
maximally induced by an NO concentration of about 1 (53). At higher NO 
concentrations the Erks are not activated (53). This increase in activity at low NO 
concentrations and decrease in activity at higher concentrations suggests that there are 
multiple factors which determine Erk activation by reactive oxygen species. While 50 |xM 
H2O2 was able to promote maximal activation of Erk2 in NIH-3T3 and smooth muscle cells, 
200 ^M H2O2 was necessary for maximal activation in HeLa, Rati and PC12 cells (54). This 
suggests some cell specificity for the activation of Erk by reactive oxygen species. 
Several studies have shown a relationship between activation of the Erks and thiol 
oxidation. This was shown either by adding N-acetylcysteine to cell cultures or by depleting 
cellular GSH before oxidant stimulation (53,54). This suggested that direct oxidation of a 
protein might be responsible for activation of the Erk pathway. For instance, the epidermal 
growth factor (EOF) receptor may be directly activated by H2O2 through thiol oxidation, 
leading to activation of the Erk pathway (54). The tyrosine phosphatase that normally 
inactivates Erk may be inhibited by direct oxidation of the active site cysteine (54). 
Dominant negative Ras, Ras-N-I7, prevented activation of Erk by H2O2, suggesting a role for 
Ras (54). Activation of Erk by NO donors in cells was also prevented by overexpression of a 
C118S mutant form of H-Ras and may therefore be a result of activation of H-Ras by S-
nitrosylation of Cysl 18 on H-Ras (56). S-nitrosylated Cysl 18 on H-Ras was produced as a 
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result of incubation of a purified truncated mutant of H-Ras (A167-190) with NO (56). The 
GTP/GDP ratio of purified truncated H-Ras was found to be increased with S-nitrosylation of 
the protein (56), and H-Ras immunoprecipitated fi-om Jurkat T cells treated with NO was also 
found to have an elevated GTP/GDP status (57), H-Ras seems to be a pivotal participant in 
Erk activation by reactive oxygen species, but inhibition of several other participants in the 
Erk signaling pathway individually or in combination also can prevent this activation. 
Dissertation organization 
This dissertation contains a general introduction, three chapters, each of which will be 
modified according to the preferences of individual journals and subnutted for publication, 
and a general summary and conclusions section. References for the general introduction and 
general summary and conclusions sections appear at the end of the dissertation. All of the 
experiments described in the three chapters were performed solely by the author with the 
helpful advice and discussion of Dr. James A. Thomas, with the exception of IC, 5B and 5C 
in Chapter II which were performed by Yanbin Ji. 
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CHAPTER I: 
GLUTATfflONE-MEDIATED PROTECTION OF CARBONIC 
ANHYDRASE III BY S-GLUTATfflOLATION 
A paper to be submitted to Archives of Biochemistry and Biophysics 
Robert J. Mallis and James A. Thomas 
Abstract 
This report presents a study of the reaction of carbonic anhydrase III, a cytosolic 
protein which contains two reactive cysteine residues, with two oxidants, hydrogen peroxide 
(H2O2) and the peroxyradical generator 2,2*-azobis(2-amidinopropane)dihydrochloride 
(AAPH). The role of reduced glutathione (GSH) in these reactions was explored. Carbonic 
anhydrase III reacts with both oxidants, producing irreversibly oxidized cysteine residues in 
the absence of GSH. In the presence of low concentrations of GSH (approximately 
equimolar to protein thiol concentrations) irreversible oxidation of carbonic anhydrase III is 
prevented and S-glutathiolation is observed. Thus, S-glutathiolation blocks sulfhydryl 
oxidation, preventing irreversible damage. Equivalent concentrations of glutathione disulHde 
(GSSG) do not produce signiflcant S-glutathiolation. These experiments suggest that a 
variety of oxidants including H202 and peroxyradicals cause S-glutathiolation by a 
mechanism that involves a direct oxidation of a protein sulfhydryl and subsequent reaction 
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with GSH to produce the S-glutathiolated protein. Glutathione disulfide (GSSG) is not an 
important intermediate in S-giutathiolation caused by either of the two oxidants studied. This 
suggests that S-glutathiolated proteins can form in cells in the absence of appreciable GSSG 
formation, and may provide a mechanism for reversible inhibition of protein sulfhydryl-
containing proteins during oxidative stress. These experiments also show that in the absence 
of sufficient GSH, oxidation reactions lead to irreversible protein sulfhydryl damage. 
Introduction 
Glutathione (GSH)'"^ is an essential component in the protection of cells from 
oxidants. It is thought to prevent oxidation of proteins by two major mechanisms. First, it 
may function as a direct scavenger of reactive oxygen species (1,2,3,4). This first function 
allows proteins to avoid becoming damaged during oxidative events. Second, it can form 
mixed disulfides with proteins, termed S-glutathiolation of proteins (5,6). This is a reversible 
oxidation of protein cysteine residues that may prevent further oxidation (6,7). Both the 
oxidation of GSH to glutathione disulfide (GSSG) and the S-glutathiolation of proteins occur 
within seconds of addition of oxidants to cell culture and are among the earliest measurable 
reactions to occur during an oxidative event (7,8,9,10,11). It is important to study the 
' Abbreviations used in this paper; AAPH, 2,2'-azobis(2-amidinopropane)dihydrochioride; DTT, 
dithiothreitoi; Erk, extracellular signal-regulated kinase; GSH, reduced glutathione; GSSG, glutathione 
disuinde; lAA, iodoacetic acid; lEF, isoelectric focusing; NEM, N-ethylmaleimide. 
^ A note on nomenclature; GSH refers ONLY to the reduced form of glutathione. GSSG refers only to 
glutathione disulfide. Oxidized glutathione may refer to several forms of glutathione including GSSG, cysteine-
glutathione disulfide, S-glutathiolated protein and S-nitrosoglutathione. 
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relationship between these two mechanisms, because both would affect the functioning of a 
wide range of proteins in cells during oxidative events. 
Carbonic anhydrase III is a cytosolic protein that can be used as a model to study S-
glutathiolation. It has two cysteine residues that are reactive to I-chloro-2,4-dinitrobenzene 
(DTNB), alkylating agents, and oxidants (12,13). It has been shown in vitro to be S-
glutathiolated by hydrogen peroxide (H2O2), diamide, GSSG and the xanthine/xanthine 
oxidase HaOi/superoxide-generating system (7,13,14). When GSH is not present to protect 
protein cysteines, xanthine/xanthine oxidase will also cause irreversible oxidation of carbonic 
anhydrase III in vitro (7). Irreversible oxidation is the formation of oxidized protein cysteine 
residues that are not reducible by thiol-disulfide exchange. These products may be either 
cysteine sulfinic acid or cysteine sulfonic acid (1,15,16,17). Both H2O2 and superoxide may 
have been responsible for the irreversible oxidation of carbonic anhydrase III by 
xanthine/xanthine oxidase (6), and so this process may be a general mechanism for damage 
to proteins by oxidants. 
Differences in protein cysteine oxidation which occur with changing GSH levels may 
be responsible for redox regulation of cellular processes (18,19,20), although the mechanism 
for this has not been studied in detail. Cellular glutathione can affect such diverse processes 
as transcription (18,19), apoptosis (20), damage to DNA (21), cell division (20), proliferation 
of cancer cells (22), susceptibility to diseases (23,24), and enzyme activity (5). GSH is 
presumed to regulate these processes either by acting as an antioxidant, preventing oxidation 
of critical cysteines (25), or through formation of GSSG and subsequent S-thiolation of the 
proteins involved (26). Because GSSG levels in cells rarely reach levels necessary for S-
glutathiolation, other mechanisms are necessary to explain S-glutathiolation in vivo. 
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Carbonic anhydrase III is in fact S-glutathioiated in hepatocytes after addition of exogenous 
oxidants such as dianiide, menadione, and t-butyl hydroperoxide (7,14). In some cases S-
giutathiolation occurs without increases in GSSG levels (8). When GSH is depleted from 
hepatocytes, menadione causes irreversible oxidation of carbonic anhydrase III (7). Thus, at 
normal GSH concentrations, reduced and S-glutathiolated forms of protein should 
predominate after oxidation. Irreversibly oxidized proteins may predominate when GSH 
concentrations are low. It has been proposed that tyrosine phosphatase is reversibly regulated 
by S-glutathiolation, and that S-glutathiolation prevents permanent inactivation of this 
protein by reactive oxygen species (27,28). 
The effects of two different oxidants, 2,2'-azobis(2-amidinopropane)dihydrochIoride 
(AAPH) and H2O2, on carbonic anhydrase III are studied here. This study will determine the 
role of GSH concentration in the protection of protein cysteine residues from irreversible 
oxidation. In particular it will define at what concentrations GSH acts as a radical scavenger 
to prevent protein oxidation, and at what concentrations it participates in S-thiolation 
reactions. Differences between the two oxidants, AAPH and H2O2, are explored in this 
context. Evidence shows that proteins are good scavengers of oxidants relative to GSH, and 
that the major role of GSH in protection of proteins is in S-glutathiolation reactions. 
Materials and Methods 
Materials. 1-Cysteine, dithiothreitol (DTT), reduced glutathione (GSH), glutathione 
disulfide (GSSG), and N-ethylmaleimide (NEM) were purchased from Sigma (St. Louis, 
MO). 2,2'-azobis(2-amidinopropane)dihydrochloride (AAPH) was purchased from Wako 
Chemicals USA (Richmond, VA). Trolox was purchased from Aldrich Chemical Company 
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(Milwaukee, WI). Ampholytes were purchased from Amersham Pharmacia Biotech, Inc. 
(Piscataway, NJ). Recombinant human erythrocyte carbonic anhydrase HI was the generous 
gift of D.L. Silverman (University of Florida, Gainesville, FL). 
Protein assay. Protein concentration was determined as described by Lowry et al. 
(29). 
Isoelectric focusing (lEF) of Carbonic Anhydrase III. Purified carbonic anhydrase III 
was separated on horizontal slab gels (5.0% (acrylamide/2.7%Bis-acrylamide)/0.3% 
ampholyte pH 4.0-6.0/1.7% ampholyte pH 5.0-8.0) at 1500V and 1.1 watt/cm for 50 minutes 
at 4°C as previously described for rat liver carbonic anhydrase III (13). The reduced form of 
the human erythrocyte enzyme separated at pl 7.6, a slightly more basic pi than the rat liver 
enzyme (reduced form pi = 7.0) used previously in this laboratory (13). Gels were stained 
with Coomassie brilliant blue R-250 and air-dried. 
Quantification of lEF gels. Gels were scanned and bands were quantified using 
Image Quant v3.3 (Molecular Dynamics Inc.). The extent of modification of carbonic 
anhydrase III was calculated by determining relative band densities within individual lanes. 
The fractional modification of carbonic anhydrase III was calculated from the following 
relationship: 
fractional modification = (density of band with 1 oxidized cysteine 
+ 2 X density of bands with 2 oxidized cysteines)/density of all bands 
Modification is reported in mole modified cysteine per mole of protein 
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Results 
GSH protects carbonic anhydrase III from irreversible oxidation by peroxyradical 
generator AAPH. Purified carbonic anhydrase III is modified specifically on up to two 
cysteine residues following addition of I-chloro-2,4-dinitrobenzene (DTNB), GSSG, 
diamide, t-butyl hydroperoxide, and xanthine/xanthine oxidase (7,12,13,14). It is modified in 
cells treated with diamide, menadione, and t-butyl hydroperoxide (7,14). 
AAPH is a compound that generates alkyl peroxyradicals by thermal decomposition 
(Scheme 1). It has been used as a model for peroxyradical-mediated oxidation both in vitro 
and in vivo (30-32). AAPH splits homolytically at 37°C to form 2 moles of alkyl radical per 
mole of AAPH (33). These radicals then react quickly with molecular oxygen to form 
peroxyradicals, which can then react with sulfhydryls. 
on, ^ 
f ?»• 
HCl HN=C—C —N=N —C=NH 2 
H2N CHa 
r 20 (jJH.] \ (;Hi 
HCl HN=C—C« 
HjN CHj 
2 HCl HN=C—COO 
HiN CHj . 
Scheme 1: Formation of peroxyradical from AAPH 
Carbonic anhydrase III reaction was analyzed by lEF. In lEF gels, migration of a protein is 
based upon the pi of the protein. Addition of negative charge to the protein causes changes 
in migration of the protein toward the acidic end of the gel. When carbonic anhydrase III is 
incubated with AAPH more acidic bands appear compared to the unreacted protein (Figure 1, 
lane 2). This shows an oxidative reaction of carbonic anhydrase m with peroxyradicals that 
was not reversible by DTT (lane 3). The oxidized forms of the protein contain additional 
negative charge as measured by lEF and may be either cysteine sulfinic acid or cysteine 
sulfonic acid (1,15,16,17). When the reaction was carried out in the presence of 300 |iM 
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AAPH 
AAPH +GSH 
reduced CAin 
1 oxidized 
cysteine 
2 oxidized 
cysteines 
DTT 
lane 1 2 3 4 5 
+ Approximate 
pi 
Figure 1. Oxidation of carbonic anhydrase 111 by AAPH in the presence of GSH. 
Carbonic anhydrase III (30 |xM) was incubated with 50 mM AAPH in the 
absence (lanes 2,3) or presence (lanes 4,5) of 300 |xM GSH for 20 minutes in 50 mM 
sodium phosphate at pH 7.4 and 37''C. Reactions were stopped by incubating the 
reaction mixtures with 20 mM N-ethylmaleimide (NEM). Carbonic anhydrase III was 
reduced by incubating the reaction mixtures with 10 mM DTT for 20 minutes before 
addition of 20 mM NEM (lanes 3 and 5). lEF gel electrofocusing was described in 
Materials and Methods. 
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GSH, an acidic band also appeared (lane 4), indicating an oxidative event. This oxidation 
was almost entirely DTT-reversible (laneS). This GSH-mediated band shift is attributed to S-
glutathiolation of carbonic anhydrase in cysteines because the reversibly oxidized carbonic 
anhydrase III is consistent with previous reports of S-glutathiolated carbonic anhydrase 111 
(7,13). 
AAPH treatment also produced a more basic form of the protein at pi 8.0 (lane 2) 
which was not DTT reversible (lane 3). The addition of positive charge to carbonic 
anhydrase III with oxidation has not been seen before. Peroxyradicals also react with carbon, 
so they are not entirely specific for sulfhydryl compounds (33,34), and this modification may 
represent the oxidation of another amino acid on carbonic anhydrase III. It was not possible 
to use SDS-PAGE to determine if there were any changes in molecular weight of carbonic 
anhydrase III caused by peptide chain breaks. The positive charge modification was not 
identified, nor was it used in quantification of damage to protein in this study. However, 
GSH does protect carbonic anhydrase HI from this modification (Figure 1, lanes 4 and 5). 
GSH may be preventing oxidative damage to carbonic anhydrase III by scavenging 
peroxyradicals in solution before they can react with the protein. It may also prevent damage 
to carbonic anhydrase III by forming disulfides with the protein, blocking the cysteine 
residues and preventing reactions with the free thiol. This second mechanism assumes that 
the cysteine residues are much more susceptible to damage than other amino acids, and 
without free sulfhydryls present, the overall reactivity of the protein is decreased. Figure 2 
shows that either 500 or 100 Trolox, a vitamin E analogue, prevented modification of 
carbonic anhydrase HI by AAPH Oanes 3 and 4) in comparison to carbonic anhydrase III that 
was incubated with AAPH alone Gane 2). If carbonic anhydrase III was treated with 20 mM 
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Figure 2: Protection of carbonic anhydrase III from AAPH-mediated oxidation. 
Carbonic anhydrase III (30 nM) was incubated with AAPH for 20 minutes and 
then treated with 20 mM NEM to stop thiol modification. Lane I, No AAPH treatment; 
lane 2, AAPH only; lanes 3 and 4, 500 |iM and 1(X) ^M Trolox, respectively, prior to 
AAPH addition; lane 5,5 minute treatment with 20 mM NEM prior to AAPH addition. 
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NEM prior to addition of AAPH (lane 5), the oxidative damage was also prevented. Thus, 
both Trolox and NEM protected against effects of AAPH. This protection included 
preventing the carbonic anhydrase III form that migrates at a more basic pi (pl= 8.0). This 
suggested that the cysteine residues were participating in propagation of radical species 
(2,25). Regardless, this experiment indicates that AAPH-mediated damage could be 
prevented both by scavenging peroxyradicals and by blocking sulfhydryl groups. 
The ratio of GSH to protein is likely to be a critical factor in preventing oxidative 
damage to proteins. To test this, carbonic anhydrase III was oxidized with AAPH in the 
presence of varying concentrations of GSH, Figure 3A shows that AAPH oxidized carbonic 
anhydrase III in the absence of GSH (lane 2) and that this oxidation remained relatively 
constant as GSH concentrations were increased from 5 |iM through 150 |iM (lanes 3-7). 
Incubation with DTT reversed little of the damage occurring In the AAPH reaction when 
GSH was not present (lane 9), but as GSH concentrations increased (lanes 10-14) the 
modification became mainly reversible. Figure 3B is a plot of the calculated reversible and 
irreversible modification in this experiment. Total modification remained quite constant 
(approximately 60% of the protein was modified) and reversible modification increased with 
GSH concentration, while irreversible modification decreased. When GSH was in fivefold 
excess over carbonic anhydrase UI concentration, irreversible oxidation was negligible. 
When GSH was further increased, protein modiHcation decreased overall, thus 1.3 mM GSH 
decreased total modification to 5%, all of which was reversible (not shown). It is likely that 
this decrease is due to scavenging of peroxyradicals by GSH before they could react with the 
Figure 3. Effect of GSH concentration on carbonic anhydrase m modification by 
peroxyradicals. 
Carbonic anhydrase III (30 jiM) was incubated with 50 mM AAPH in the presence of 
varying concentrations of GSH for 20 minutes at 37°C in sodium phosphate buffer pH 7.4. 
Reactions were stopped by incubating the reaction mixtures with 20 mM N-ethylmaieimide 
(NEM). Carbonic anhydrase III was reduced by incubating the reaction mixtures with 10 
mM DTT for 20 minutes before addition of 20 mM NEM (lanes 8-14). A. lEF separation of 
AAPH-treated carbonic anhydrase HI. Concentrations of GSH are shown below each lane, U 
= no AAPH added. B. Analysis of reversible modification and irreversible modification 
dependence on GSH concentration. Fractional modification (modification) of carbonic 
anhydrase III was determined by analysis of the lEF separation in part A as described in 
Materials and Methods. Reversible modiHcation is the difference in fractional modification ^ 
between DTT-untreated and DTT-treated lanes. Irreversible modification is the fractional 
modification in DTT-treated lanes. C. Carbonic anhydrase HI (30 nM) was incubated with 
either 50 mM AAPH and 150 ^iM GSH or with 75 ^iM GSSG at pH 7.4 and at 3TC for 20 
minutes. Reversible modification was determined as described in part B of this figure. 
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protein. 
It has been suggested that reactive oxygen species cause S-glutathiolation of proteins 
by reacting with two GSH molecules to form GSSG. GSSG could then react with protein 
cysteine by thiol-disulfide exchange to form the S-glutathiolated protein (26). Figure 3C 
shows data relevant to this idea. When carbonic anhydrase III was incubated with 75 ^iM 
GSSG (the maximum that could be produced by oxidation of 150 |xM GSH), carbonic 
anhydrase III was not significantly modified. This is in comparison to 30% modification in 
the reaction of AAPH with carbonic anhydrase III in the presence of 150 ^iM GSH. Thus, 
GSSG cannot be an intermediate in S-glutathiolation of carbonic anhydrase III by AAPH. 
This supports previous reports that oxidants react directly with proteins or GSH to form an 
oxidized intermediate, and that this intermediate in turn reacts to form the S-glutathiolated 
product (6,8). 
When carbonic anhydrase III concentration was varied from 30 ^iM to 240 ^iM while 
holding GSH concentration at 150 ^M, with AAPH treatment, it was found that reversible 
modification increased in proportion to carbonic anhydrase III concentration (Figure 4). 
Irreversible modification was negligible in this experiment (not shown). S-glutathiolation 
was about 30% at 30 carbonic anhydrase III and decreased only slightly to about 20% 
modification when carbonic anhydrase concentration was 240 |xM. Since the amount of S-
glutathiolated carbonic anhydrase m increases with carbonic anhydrase III concentration, it 
appears that carbonic anhydrase m is trapping peroxyradicals very efHciently. When 
carbonic anhydrase m concentration is 240 there is 40 |iM of protein bound glutathione, 
accounting for 25% of the total GSH available. S-glutathiolated protein therefore accounts 
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Figure 4. Carbonic anhydrase m concentration effiects on AAPH reaction. 
AAPH (50 mM) was incubated with 30 nM to 240 ^iM carbonic anhydrase III in 
the presence of 150 (iM GSH at SVC for 20 minutes. Reactions were stopped by 
incubating the reaction mixtures with 20 mM N-ethylmaleimide (NEM). Carbonic 
anhydrase III was reduced by incubation of the reaction mixtures with 10 mM DTT for 20 
minutes before addition of 20 mM NEM (lanes 3 and 5). Carbonic anhydrase III was then 
separated by lEF as described in Materials and Methods. Fractional modiHcation of 
carbonic anhydrase III was determined by analysis of the lEF separation as described in 
Materials and Methods. Reversible modiHcation is the difference in fractional 
modification between DTT-untreated and DTT-treated lanes. Irreversible modification is 
the fractional modification in DTT-treated lanes. 
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for a signiflcant fraction of oxidized glutathione in this experiment. This shows that carbonic 
anhydrase III is an efficient scavenger of AAPH generated radicals via S-glutathiolation. 
GSH protects carbonic anhydrase III from irreversible oxidation by H2O2. H2O2 will 
react directly with sulfhydryls to form sulfenic acid (scheme 2) (25). The sulfenic acid will 
then react rapidly with free thiols to form a disulfide. In the absence of available thiols, 
sulfenic acid will continue to react with H2O2 to form sulfmic acid and sulfonic acid (15,16). 
When carbonic anhydrase III was incubated with H2O2 for less than 10 minutes (Figure 5A) 
an acidic band (pi = 7.2) appeared, analogous to that produced by the AAPH reaction 
(Figures 1,3). In the absence of GSH (Figure 5A.), the modification was not reversible with 
DTT treatment (compare right and left half of the same gel). Unlike AAPH, H2O2 did not 
produce a more basic protein band at pl=8.0 (not shown). This is because H2O2 oxidation is 
probably more specific for cysteine than is oxidation generated by AAPH. When GSH was 
added to the reaction (Figures 5B, 5C), the oxidative modification to carbonic anhydrase III 
was more pronounced and completely reversible (compare right and left half of each gel). 
Figure 5D quantifies the oxidatively modiHed carbonic anhydrase m as shown in parts A, B, 
and C of this figure. As GSH concentration increased, reversible modiHcation (open 
symbols) increased and irreversible modification (closed symbols) decreased. This indicates 
> RSSR* RSOH 
Scheme 2: Reactions of HjO, with RSH. 
Figure 5. Oxidation of carbonic anliydrase m with H2O2 and GSH. 
Carbonic anhydrase III (10 nM) with the indicated concentration of GSH was 
incubated with 2 mM H2O2 at 37°C in 20 mM sodium phosphate buffer pH 7.4. Reactions 
were stopped at the indicated time by incubating the reaction mixtures with 20 mM N-
ethylmaleimide (NEM). Carbonic anhydrase HI was reduced (right half of each gel) by 
incubating the reaction mixtures with 10 mM DTT for 20 minutes before addition of 20 mM 
NEM. lEF separations were performed as described in Materials and Methods. A. Carbonic 
anhydrase III + H:02 without addition of GSH. B. Carbonic anhydrase III + 150 |iM GSH + 
H2O2. C. Carbonic anhydrase in + 450 nM GSH + H2O2. D. Analysis of the reaction 
between carbonic anhydrase in, GSH and H2O2. Fractional modiHcation of carbonic 
anhydrase lU was determined by analysis of the lEF separations in parts A, B, and C of this 
figure as described in Materials and Methods. Reversible modification is the difference in 
fractional modification between DTT-untreated and DTT-treated lanes. Irreversible 
modification is the fractional modification in DTT-treated lanes. 
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that reversible modification of carbonic anhydrase in is a fast reaction in comparison to 
irreversible modification and is favored when substrate (i.e. GSH) is available. Total 
modification (reversible + irreversible) at 150 nM or 450 |aM GSH was approximately 
double the total modification when GSH was absent. Again this suggests that S-
glutathiolation is fast in comparison to irreversible oxidation. 
The concentration dependence for the reaction between carbonic anhydrase III, GSH 
and H2O2 was determined at two concentrations (10 |iM and 30 |iM) of carbonic anhydrase 
III. Figure 6A shows that reversible modification (open symbols) reached maximal levels at 
50 i^M GSH at both protein concentrations. Carbonic anhydrase III was also completely 
protected from irreversible oxidation (closed symbols) by 50 |iM GSH. At GSH 
concentrations below 50 nM, irreversible oxidation of carbonic anhydrase III was dependent 
on carbonic anhydrase III concentration. When carbonic anhydrase III concentration was 30 
)xM, H2O2 caused more irreversible oxidation at 5 (aM and 15 (iM GSH than when carbonic 
anhydrase III concentration was 10 |iM. As noted above, 50 GSH completely protected 
30 ^iM carbonic anhydrase III from irreversible oxidation. Thus, protection of proteins by 
GSH was most efficient when GSH:protein molar ratios approached one. When 5 GSH 
was present, S-glutathiolated protein accounted for 50% and 100% of the GSH available in 
reactions of H2O2 with 10 nM and 30 |iM carbonic anhydrase III, respectively. Thus, when 
GSH is limiting, S-glutathiolation is likely to be the primary function of GSH in protection of 
carbonic anhydrase III from irreversible oxidation by H2O2. 
At 1.3 mM GSH, 50% of the carbonic anhydrase in was S-glutathiolated, and none 
was irreversibly oxidized (data not shown). Carbonic anhydrase in was modified by H2O2 
Figure 6. Effect of GSH concentration on carbonic anhydrase m modification by 
H2O2. 
Carbonic anhydrase III (10 nM or 30 ^ iM) with the indicated concentrations of GSH 
was incubated with 2 mM H2O2 for 10 minutes at 37°C and at pH 7.4. Reactions were 
stopped by incubating the reaction mixtures with 20 mM N-ethylmaleimide (NEM). 
Carbonic anhydrase III was reduced by incubation of the reaction mixtures with 10 mM DTT 
for 20 minutes before addition of 20 mM NEM. Carbonic anhydrase III was then separated 
by lEF as detailed in Materials and Methods. Fractional modification of carbonic anhydrase 
III was determined by analysis of the lEF separation as described in Materials and Methods. 
Reversible modification is the difference in fractional modification between DTT-untreated 
and DTT-treated lanes. Irreversible modification is the fractional modification in DTT-
treated lanes. B. Carbonic anhydrase III (30 ^iM) was incubated with either 2 mM H2O2 and 
150 nM GSH or with 75 nM GSSG for 10 minutes at 2TC and at pH 7.4. Reactions were 
stopped and protein was reduced as in part A. Modification was analyzed as in part A of this 
figure. 
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even when GSH concentrations were 130 times greater than the protein concentration. This 
confirms that carbonic anhydrase III is a good scavenger of H2O2 compared to GSH. 
GSSG formation could not account for the extent of S-glutathiolation seen in the 
reaction of carbonic anhydrase III with AAPH (Figure 3C). Similarly, the reaction between 
carbonic anhydrase III and 75 GSSG produces little modification in comparison to that 
of carbonic anhydrase III, 150 GSH, and H2O2 (Figure 6B). GSSG clearly is not an 
intermediate in the S-glutathiolation of carbonic anhydrase III by H2O2. As with AAPH, it is 
likely that H2O2 reacts with either carbonic anhydrase III or GSH, which in turn reacts to 
form S-glutathiolated protein. 
GSH has been shown to be the major thiol participating in S-thiolation reactions in 
cells (8). This may be because of a special affinity of protein S-thiolation sites for GSH, or 
because of the relatively high concentration of GSH (35) compared to other low molecular 
weight thiols in cells. We therefore studied whether cysteine would also protect carbonic 
anhydrase III from oxidative damage by H2O2. When carbonic anhydrase III was incubated 
with H2O2,30% of the protein was modified by a single negative charge (Figure 7, second 
bar). Cysteine prevented this modification by H2O2 as shown by its inhibition of negative 
charge addition (third bar). In order to be able to detect the neutrally charged S-cysteylated 
carbonic anhydrase III, the protein was reacted with the negatively charged alkylating agent 
iodoacetic acid (lAA). S-cysteylation would appear in this assay as an inhibition of lAA 
derivitization, while irreversible oxidation and lAA derivitization would be indistinguishable 
(36). When carbonic anhydrase OX is reacted with lAA, it is modified with a negative 
charge on 1 site on 100% of the protein (fourth bar), which agrees with previously published 
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Figure 7. Protection of carbonic aniiydrase III from HjO} oxidation by cysteine. 
Carbonic aniiydrase III (10 |xM) was incubated with 2 mM H2O2 in the absence 
and presence of 150 |xM cysteine at 37°C and at pH 7.4 for 10 minutes. The reactions 
were stopped with either 10 mM lAA or 10 mM NEM as indicated. lEF was performed 
as described in Materials and Methods. Addition of negative charge was then calculated 
as the fractional modification as described in Materials and Methods. 
reports of rat liver carbonic anhydrase HI (36). If carbonic anhydrase HI is incubated with 
H2O2 before lAA derivitization, there is a modest increase in negatively charged 
modification (fifth bar). This small increase indicates that little of the modification caused 
by H2O2 occurred on the thiol which is does not react with lAA. Only 30% of the protein is 
modified with a negative charge when cysteine is present during the reaction of H2O2 with 
carbonic anhydrase III (sixth bar), indicating that more than 70% of the protein is S-
cysteylated. Therefore GSH may participate in S-thiolation reactions largely due to its 
concentration in cells relative to the concentrations of other low molecular weight thiols. 
Discussion: 
From the data presented here three distinct mechanisms for protection of protein 
cysteines can be proposed (Figure 8): 1) The oxidant reacts first with protein cysteine to 
form an activated protein cysteine, either protein thiyl radical, protein cysteine thioperoxide, 
protein cysteine thioperoxyradical, or protein cysteine sulfenic acid (5,18,25,37). This 
activated cysteine then reacts with GSH to form the S-glutathiolated protein (Reaction 1). 
2) The oxidant reacts first with GSH to form an activated form of glutathione, which then 
reacts with protein cysteine to form S-glutathiolated protein (Reaction 2). 3) The oxidant 
reacts first with GSH to form an activated form of glutathione, which then reacts with 
another molecule of GSH to form GSSG (Reaction 3). In reaction 4, the oxidant reacts with 
the protein to form an activated intermediate that, in the absence of GSH, leads to irreversible 
oxidation. 
Oxidation of carbonic anhydrase III with either AAPH or H2O2 produced considerable 
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Figure 8: Mechanisms for Protection of Protein Cysteine (ProteinSH) from 
Irreversible Oxidation by Reactive Oxygen Species (ROS). 
Reaction 1: Reactive oxygen species (ROS) react with the protein to form an 
activated intermediate, ProteinS* (e.g. thiyl radical or cysteine sulfenic acid), which then 
reacts with GSH to form S-glutathioIated protein, ProteinSSG. Reaction 2: ROS react 
with GSH to form an activated intermediate, GS*, which then reacts with ProteinSH to 
form S-glutathiolated protein. Reaction 3; ROS react with GSH to form an activated 
intermediate that then reacts with GSH to form GSSG. Reaction 4: ROS react with the 
protein in the absence of GSH to form an activated intermediate which can then react with 
molecular oxygen to form ureversibly oxidized protein, ProteinSj,,. 
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irreversible oxidation in the absence of GSH, which validates reaction 4. 
Multiple acidic bands are generated on the lEF separation which are not reducible by 
DTT treatment (Figure 1). These bands also occur in oxidation of carbonic anhydrase III by 
other mechanisms (7,36). Reactions between thiols and reactive oxygen species may result 
in formation of sulfinic acid or sulfonic acid (1,15,16,17), both of which are negatively 
charged sulfur compounds. It therefore seems likely that AAPH and HoOt treatment of 
carbonic anhydrase III results in the formation of protein cysteine sulfmic or sulfonic acid. 
GSH prevented irreversible oxidation by AAPH or H2O2 (Figure 8, Reactions 1,2 and 
3) and simultaneously participated in S-glutathiolation of carbonic anhydrase III (reactions 1 
and 2). The protection of carbonic anhydrase m and formation of S-glutathiolated protein 
was dependent on the concentration of GSH. Additionally, as S-glutathiolation increased, 
irreversible oxidation decreased in a GSH-dependent manner. This suggests that S-
glutathiolation is linked to prevention of irreversible oxidation (5-7). 
At lower GSH concentrations, reactions 1 and/or 2 are important, since S-
glutathioiated protein is a measured endpoint in both reactions. The increase in total protein 
modiHcation at low GSH concentrations suggests either that reaction 2 is an important 
mechanism, or that formation of irreversible oxidation products (reaction 4) is slower than 
the S-glutathiolation reaction (i.e. the second step) in reaction I. Because formation of 
cysteine sulfinic acid and cysteine sulfonic acid require multiple oxidation events, this 
supposition is reasonable. S-glutathiolation of carbonic anhydrase lU is 50% mole/mole at 
GSHrprotein ratios of 130:1 in the H2O2 reaction and 30% mole/mole when GSH:protein 
ratios vary from 5:1 through 1:1.5 in the AAPH system. This indicates that reaction 1, which 
postulates interaction of oxidant with the protein, is important. The fact that reaction 4 
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occurs at all is further proof that the protein must react directly with the oxidant as it does in 
the first step of reaction I. 
GSSG formation is not an important mechanism of S-glutathiolation in AAPH or 
HaOa-mediated oxidation, and so reaction 3 would be more important only at very high 
GSH:protein ratios. In the AAPH reaction, GSH.protein ratios of 130:1 produced 5% S-
glutathiolation, while the maximal S-glutathiolation (at lower GSH concentrations) was 30%. 
In contrast, 130:1 GSH:protein ratio in the H2O2 reaction produced 50% S-glutathiolation 
versus 60% at maximal levels. This shows that carbonic anhydrase III is a more erucient 
scavenger of H2O2 than it is of AAPH-generated peroxyradicals. However, because 
GSHrprotein thiol ratios are close to 1:1 by most estimates, and certainly do not reach 130:1, 
the significance of very high GSH:protein ratios is questionable. 
The reaction of H2O2 with carbonic anhydrase III and cysteine suggests that cysteine 
is as effective as an S-thiolating agent as GSH when carbonic anhydrase III is the protein 
substrate. If carbonic anhydrase III is typical of cytosolic proteins with reactive cysteines, 
then the predominance of S-glutathiolated proteins in oxidized cells is likely the result of the 
greater concentration of GSH in cells (8). Since carbonic anhydrase III does not appear to 
have a binding site for GSH, this result should be relevant to many surface-exposed cysteine 
sites on proteins. 
In conclusion, GSH participates in oxidative reactions with proteins to form mixed 
disulfides. S-glutathiolation appears to occur by reaction of either protein cysteine or GSH 
with the reactive oxygen species, which then reacts to form S-glutathiolated protein. The 
reaction between cysteine and carbonic anhydrase m argues against the necessity for specific 
interactions between protein and GSH for S-glutathiolation. GSSG formation is not a 
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significant mechanism for S-glutathiolation in either of the systems studied. The formation 
of S-glutathiolated proteins prevents formation of irreversibly oxidized species in vitro at 
GSH:protein ratios of 1:1 up to at least 5:1 and in the case of H2O2, up to at least 130:1. 
Direct scavenging of reactive oxygen species by GSH is likely to be important at very high 
GSH:protein ratios although GSH seemed a more effective scavenger of AAPH than of 
H2O2. Because GSH:protein ratios in cells are more likely to be closer to 1:1 than 130:1 (8), 
the formation of S-glutathiolated protein is probably the physiological mechanism for 
protection of protein sulfhydryls against permanent inactivation by the formation of 
irreversibly oxidized species. Furthermore, the reaction mechanisms postulated here (Figure 
8, reactions 1 and 2) suggest that regulation of proteins can occur through S-glutathiolation 
without the necessity of forming GSSG as an intermediate. This makes S-glutathiolation a 
plausible initial event in the activation of signaling cascades by oxidants. While the 
prevention of irreversible oxidation by S-glutathiolation has obvious value in preserving the 
function of cysteine-containing proteins, irreversible oxidation of cysteines may contribute to 
degeneration of signaling seen in aging, cancer and other disease states (38-40). 
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CHAPTER n: 
S-GLUTATfflOLATION OF H-RAS IN VITRO AND IN VIVO 
A paper to be submitted to die Journal of Biological Chemistry 
Robert J. Mallis, Yanbin Ji, and James A. Thomas 
Abstract 
The oxidation of H-Ras thiols was studied in both the pure protein and in NIH-3T3 
cells. Purified H-Ras was found to be modified by thiol oxidants including hydrogen 
peroxide (H2O2), S-nitrosoglutathione, diamide, GSSG, and cystamine, producing up to four 
modified forms. Since H-Ras is known to contain four reactive sulfhydryls, these results 
suggest that all four cysteines can react with a variety of oxidants. Both S-nitrosylated and 
S-glutathiolated forms of H-Ras were identified by separation on electrofocusing gels. S-
nitrosoglutathione appears to cause S-nitrosylation of H-Ras on four cysteine residues as 
determined by lEF. Reduced glutathione (GSH) mediates S-glutathiolation by H2O2 on at 
least one cysteine of purified H-Ras as measured by lEF and HPLC. Either GSSG or 
diamide + GSH appears to S-glutathiolate at least two cysteine residues of purified H-Ras. 
lodoacetic acid reacts with three cysteine residues. 
In intact NIH-3T3 cells, H-Ras was S-thiolated by diamide. In cells expressing a 
CI18S mutant or a C181S/C184S double mutant, H-Ras was also S-thiolated. These results 
suggest that H-Ras can be oxidatively modified on multiple thiols in vivo and that at least one 
of these thiols is normally lipid modified. Thus, cellular oxidative stress may lead to 
competition between oxidant and lipid for reaction with H-Ras thiols. This might alter the 
membrane association and activity of H-Ras. 
Introduction 
H-Ras, a small monomeric guanine nucleotide binding protein (G-protein) is essential 
in most cells for proliferation and differentiation (1). It participates in the well-studied 
extracellular signal-regulated kinase (Erk)' pathway and has been implicated in relaying 
oxidative signals through this pathway (2-5). Studies have shown activation of Erk and other 
components of the Erk pathway when cells were treated with H2O2, NO, superoxide, sodium 
nitroprusside, and S-nitroso-N-acetylpenicillamine. The oxidative response of the Erk 
pathway may be a direct result of changes in the GTP/GDP ratio of H-Ras, altered interaction 
of H-Ras with an effector molecule, modiHcation of one of the effector molecules on the 
interaction with H-Ras, or process that leaves H-Ras unchanged (3,4,6,7). 
Cell culture experiments using Jurkat cells showed that, upon treatment of the cells 
with nitric oxide (NO) related compounds, the Erks were activated and the GTP/GDP ratio of 
the H-Ras protein was altered (3,6). In vitro results showed that an NO-treated truncated 
mutant of H-Ras lacking the three c-termlnal cysteine residues was specifically modiHed by 
' Abbreviations used in this paper; DTT, dithiolhreitol; Erk, extracellular signal-regulated kinase; 
GSH, reduced glutathione; GSSG, glutathione disulHde; lAA, iodoacetic acid; lAM, iodoacetamide; lEF, 
isoelectric focusing; NEM, K-ethylmaleimide. 
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S-nitrosylation on Cysl 18 (6). The authors suggest that a direct modification of Cysl 18 by 
NO may be responsible for the activation of H-Ras in cells treated by NO gas, and that S-
nitrosylation of H-Ras was at least partially responsible for the proliferative effects of NO in 
cells. Because CysllS resides on a loop that has contact with the guanine nucleotide, 
modification of this cysteine may directly affect the bound GTP/GDP ratio of H-Ras, thus 
changing its activity (8). 
H-Ras possesses three other cysteine residues that could be modified in vivo, the 
effects of which would likely oppose that suggested for the modification of Cysl 18. For 
example, it has been shown that NO-related oxidants can prevent palmitoylation of some 
proteins in cells (9). Since Cysl8l and Cysl84 of H-Ras are palmitoylated, a transient 
modification in vivo, a significant portion of these residues would potentially be available for 
modification (10,11). Oxidation of one or both of these residues could alter membrane 
association of H-Ras and thus affect the signal transduction properties of the protein. 
Mutagenesis studies have confirmed that these residues are essential for transformation of 
cells by an otherwise oncogenic H-Ras mutant form (11). 
Cysl86 of H-Ras has been shown to be famesylated via a thioether linkage. 
Famesylation of the protein allows it to associate with cellular membranes (10,12-14). 
Although the H-Ras protein is thought to remain famesylated for the lifetime of the protein, a 
significant fraction of these cysteines are available in most cells (11,15). It is possible that 
oxidative modification of this residue occurs in cells. Oxidation of this residue might 
inactivate H-Ras, since famesylation and membrane association is thought to be essential for 
its function (10,12-14). 
43 
Cells are continually exposed to oxidative conditions that can potentially damage 
many of their components (16,17). S-glutathiolation of proteins is directly related to the 
oxidation of proteins in cells (17). S-glutathiolation is a two-electron oxidation of protein 
cysteine and free reduced glutathione (GSH) to a disulfide of protein cysteine-glutathione 
disulfide. It can occur when a protein cysteine is oxidized and subsequently reacts with GSH 
to form the mixed disulfide (18,19). The S-glutathiolated protein may be reduced back to its 
original thiol form by the dithiol protein glutaredoxin (20). The availability of GSH to form 
S-glutathiolated proteins may be linked to the prevention of irreversible Hamage of these 
sulfhydryls (18,19, see chapter I). 
If H-Ras is found to be S-glutathiolated or otherwise oxidatively modified, it would 
be an important step in understanding primary mechanisms of oxidative regulation of signal 
transduction pathways. This paper provides evidence that H-Ras may be oxidatively 
modified on four separate cysteine residues in vitro. We further show that while S-
nitrosylation may modify all four of these residues, S-glutathiolation occurs primarily on two 
of four possible reactive cysteine residues. We also provide evidence that one or more sites 
are available to S-glutathiolation in vivo, and that at least one of these sites is a cysteine 
normally required for lipidation of H-Ras. 
^ A note on nomenclature; GSH refers ONLY to the reduced form of glutathione. GSSG refers only to 
glutathione disulfide. Oxidized glutathione may refer to several forms of glutathione including GSSG, cysteine-
glutathione disulfide. S-glutathiolated protein and S-nitrosoglulathione. 
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Materials and Methods 
Materials. lodoacetic acid (lAA), iodoacetamide (lAM), N-ethylmaleimide (NEM), 
reduced glutathione (GSH), dithiothreitol (DTT), glutathione disulHde (GSSG), rat anti-
mouse alkaline phosphatase-conjugated antibody and goat anti-rat alkaline phosphatase-
conjugated antibody were from Sigma (St. Louis, MO). Cell culture reagents were purchased 
from GIBCO-BRL (Gaithersburg, MD) with the exception of bovine calf serum (BCS), 
which was purchased from HyClone (Logan, UT). Ampholytes were purchased from 
Amersham-Pharmacia, Inc (Piscataway, NJ). Recombinant human H-Ras and agarose-
conjugated and soluble Ab-l were purchased from Calbiochem-Novabiochem (San Diego, 
CA). Monoclonal Ab 146-03E4 (Ab 146) was purchased from Quality Biotech (Camden, 
nj). 
Protein assay. Protein concentration was determined as described by Lowry et. al. 
(25). 
Preparation of H-Ras Protein. Purified wildtype H-Ras (3 mg/ml) was completely 
reduced with 10 mM DTT for 30 minutes at room temperature. The protein was then 
dialyzed for 24 hours at 4°C against 20 mM Tris-Cl pH 8.0, containing 500 |iM DTT. DTT 
was included in dialysis buffer to prevent progressive oxidation of H-Ras that occurred in the 
absence of DTT (data not shown). Dialyzed protein (approximately 1 mg/ml) was stored for 
less than one week at 4°C before use. 
Preparation of S-nitrosothiols. S-nitrosoglutathione was prepared as previously 
described in (21) and used immediately after preparation. Briefly, 220 |il each of 220 mM 
GSH and 220 mM sodium nitrite were mixed with 25 ^l of 4.0 N HCl and incubated in the 
dark at room temperature for 10 minutes. The solution was then neutralized with 25 |il of 4.0 
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N NaOH to give a final concentration of approximately 100 mM S-nitrosoglutathione. The 
final concentration was calculated from absorbance at 334 nm using the extinction coefficient 
767 cm-' (24) 
Isoelectric focusing (lEF) of H-Ras. Purified H-Ras was separated on horizontal slab 
gels (5.0% acrylamide/2.7%Bis-acrylamide/l% ampholyte pH 3.5-5.0/1% ampholyte pH 4.0-
6.0) at 1500V and 0.5mAmp/cm' for 50 minutes. Approximately 1 ^g of H-Ras was applied 
to each lane. Gels were stained with Coomassie Brilliant Blue as previously described (21). 
Isoelectric focusing/Westem Blot analysis of H-Ras. H-Ras was separated by lEF as 
previously described (21) and transferred to Immobilon-P (PVDF) (Millipore, Inc, Bedford, 
MA) membrane using a Bio-Rad Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad 
Laboratories, Hercules, CA) according to the recommendation of the manufacturer. H-Ras 
was visualized with the Ab 146 primary antibody (1:3000 dilution) and rat antimouse 
alkaline phosphatase secondary Ab (1:10000 dilution) with the exception of the truncated 
mutant (A167-190) which was visualized using Ab-1 as the primary antibody (1:3,000 
dilution) and goat anti-rat secondary antibody (1:10,000 dilution). Bands were visualized 
with p-nitroblue tetrazolium chloride (NBT)/5-bromo-4-chloro-3-indoyl phosphate (BCIP). 
Quantification oflEFgels. Gels were scanned and bands were quantified using 
Image Quant v3.3 (Molecular Dynamics Inc.). The extent of modification of H-Ras was 
calculated by detennining relative band densities within individual lanes. The fractional 
modification of H-Ras was calculated from the following relationship: 
fractional modification = (density of band with 1 oxidized cysteine 
+ 2 X density of bands with 2 oxidized cysteines 
+ 3 X density of bands with 3 oxidized cysteines)/density of all bands 
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Modification is reported in mole modified cysteine per mole of protein 
Modification ofH-Ras in soluble extracts ofE. coli overexpressing H-Ras. As 
described by Ji. et. al. (21), E. coli strain JM 105 containing the gene for H-Ras wildtype, 
C181S/C184S or truncated (A167-190) mutant donated by S. Campbell (University of North 
Carolina, Chapel Hill, NC) inserted in a pAT vector (22) were grown at 37°C in Luria broth 
to an OD of 1.2-1.5 (at 600nm) and induced by addition of isopropyI,P-D-
thiogalactopyranoside for 3 hours. The cells were then centrifuged at 16,000 x g for 10 
minutes. The pellet was washed with 20 mM Tris-HCl buffer (pH 7.2), 100 mM NaCl, 5 
mM MgCb, and 1 mM phenylmethyl sulfonyl fluoride (PMSF). After centrifugation at 
16,000g for 10 minutes, cells were resuspended to 0.2 g cell paste/ml in 20 mM p-
glycerophosphate-HCl (pH 7.0) and sonicated for 30 seconds. The soluble fraction was 
obtained by ultracentrifugation in a Beckman Airfuge at 160,000 x g for 30 minutes. 
Cell Culture. NIH-3T3 fibroblasts were obtained from American Type Culture 
Collection (ATCC) and cultured according to their recommendations (10% CO2, Dulbecco's 
Modified Eagle Medium (DMEM) + 2mM Glutamine + 0.2mM Sodium Pyruvate + 10% 
BCS + 100 units/ml each of Penicillin and Streptomycin). NIH-3T3 cells overexpressing 
wildtype and CI 18S H-Ras were generous gifts from L.A. Quilliam (Indiana University 
School of Medicine, Indianapolis, IN) and were cultured according to ATCC 
recommendations for NIH-3T3 cells. NIH-3T3 cells overexpressing C181S/C184S H-Ras 
were the generous gift of B.M. Willumsen (University of Copenhagen, Copenhagen, 
Denmark.) and were cultured according to ATCC reconunendations for NIH-3T3 cells. 
Cellular experiments. NIH-3T3 cells were grown to confluence (assessed visually, 
approximately 1-2 x 10*^ cells/35 nun plate) and the medium was changed. Experiments were 
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started 24 hours later. Experiments were conducted in phosphate buffered saline (PBS) to 
avoid any oxidative artifacts associated with interactions between DMEM and added 
oxidants. PBS was added to cells 5 minutes prior to the addition of oxidant to avoid 
oxidative artifacts associated with change of medium. 
Analysis of Cellular Low Molecular weight thiols. NIH-3T3 cells were rinsed twice 
with ice cold PBS and lysed with 10% perchloric acid. Plates were scraped and the soluble 
and precipitated materials were collected and stored at -KfC for <l week. To remove 
precipitated proteins, samples were centrifiiged at -15,000 x g for 10 minutes. A fraction 
(200 |il) of the supernatant was used for the HPLC analysis of low molecular weight thiols 
while the pellet was stored at -20°C for < 1 week for subsequent protein assay. 
Anion Exchange HPLC Analysis of Low Molecular Weight Thiols. Low molecular 
weight thiols were analyzed as described by Fariss and Reed (23) with some modifications. 
Briefly, iodoacetic acid (lAA) was added to the 200 |j,l sample containing 10% perchloric 
acid to a final concentration of 130 mM and the pH was raised to ~8.5 by addition of dry 
potassium bicarbonate. An equal volume of fluorodinitrcbenzene (FDNB) in 100% ethanol 
was added to a final concentration of 0.5% and incubated overnight at 4''C. Samples were 
separated on an aminopropyl anion exchange column. Compounds were identified by 
coelution with authentic pure compounds. 
Specific activity of cellular glutathione. Cells labeled with Tran^^S-label (ICN 
Pharmaceuticals, Inc., Costa Mesa, CA) were lysed and treated as above for analysis of low 
molecular weight thiols. Samples were prepared for anion exchange HPLC analysis of low 
molecular weight thiols as described. The GSH and GSSG peaks were collected and counted 
using a Beckman LS-IOOC scintillation counter. 
Assay of S-thiolated H-Ras. S-thiolated H-Ras was determined using a modification 
of tlie procedure of Fariss and Reed (23). Briefly, H-Ras was precipitated by adding 70% 
perchloric acid to a final concentration of 10%. After centrifiigation at 15,000 x g, the 
supernatant was removed and used for quantitation of GSSG/GSH by HPLC. The pellet was 
washed with ice-cold 100% ethanol. The pellet was then resuspended in 50 mM MOPS pH 
8.0 ± 50 mM DTT and incubated for 60 minutes at 37°C. Perchloric acid was again added to 
a final concentration of 10% and the sample was centrifuged at 15,000 x g. The supernatant 
was recovered and thiols were analyzed by anion exchange HPLC as described above. 
Results 
Characterization of H-Ras. Separation of purified H-Ras by SDS-PAGE revealed 
only a single band (Figure lA). The protein appears to be >90% pure as assessed by the 
dilution series. Isoelectric focusing (lEF) can be used to separate soluble proteins differing 
in charge. Since S-glutathiolation adds a single negative charge to proteins, the modified 
forms migrate at a more acidic pi than the unmodified proteins. Figure IB shows the effect 
of addition of either uncharged iodoacetamide (lAM), or negatively charged iodoacetic acid 
(lAA) on H-Ras. The lAM-treated lane (left lane) shows two bands that have been 
previously reported to have isoelectric points (pis) of 4.3 and 4.1 (21). The band that 
migrates at 4.3 is probably the reduced form of the protein (21), while the band at 4.1 is 
probably the protein with a single oxidized cysteine residue. Approximately 20% of the 
pure, unmodified protein was present as a more acidic band. The lAA-treated protein (right 
lane) focuses in two acidic bands with pis of 4.0 and 3.9. These bands are thought to result 
from 2 and 3 modifications with the negatively charged reagent. Approximately 90% of the 
Figure 1. Characterization of H-Ras preparation. 
A. H-Ras was separated by SDS-PAGE as described in Materials and Methods. B. 
H-ras (10 ^iM) was reacted with 10 mM DTT for 30 minutes at pH 8.0 and 37°C. The 
reaction mixture was diluted by one-half and H-Ras was alkylated with either 20 mM lAM in 
20 mM Tris-Cl buffer (pH 8.0) or 40 mM lAA in 60 mM Tris base (final pH = 7.5) and room 
temperature in the dark. The protein (1 |ig) was then separated by EEF as described in 
Materials and Methods. C. lEF/Westem blot of purified H-Ras and extracts of E. coli which 
overexpress wildtype and mutant forms of H-Ras treated with lAM and lAA. E. coli 
overexpressing H-Ras were cultured and lysed as described in Materials and Methods. 
Extracts and purified H-Ras were then treated with either 40 mM lAM or 40 mM lAA at pH 
7.5 for 15 minutes. Extracts and purified H-Ras were then separated and visualized by 
lEF/Westem blot analysis as described in Materials and Methods. 
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lAA-treated H-Ras has 3 additional negative charges while 10% has two negative charges 
added or 2.9 moles adducts /mole of H-Ras. lAA, therefore, readily reacts with at least 3 
cysteines in native H-Ras. Figure IC shows EEF separations coupled with western blot 
analysis of either purified H-Ras or E. coli extracts containing wildtype or mutant H-Ras. 
Purified H-Ras (lanes 1,2) and wildtype extracts (lanes 3,4) show mobilities identical to each 
other after JAM or lAA treatment. H-Ras in which the cysteines at positions 181 and 184 are 
mutated to serine (C181S/C184S, lanes 5,6) shows lAA reactivity with only one cysteine. 
The truncated form of H-Ras, which does not have the three c-terminal cysteine residues, 
does not react with lAA (lanes 7,8). This experiment therefore identifies the three lAA-
reactive cysteines as cysteines 181, 184, and 186. Cysteine 118, which is surface exposed in 
X-ray crystal structures and NMR sUuctures of H-Ras (8,27), does not appear to be reactive 
towards lAA. 
Reactions of H-Ras with disulfides. The reaction of a protein with GSSG to form the 
S-glutathiolated protein, while probably of little physiologically importance (28, see chapter 
I), demonstrates the potential reactivity of H-Ras cysteines to S-glutathiolation (29). Figure 
2 shows the reaction of H-Ras under conditions that enhance the rates of thiol-disulfide 
exchange, i.e. pH 8.0,20 mM GSSG. Lanes 1 and 2 are control lanes that identify the 
multiple charge forms of H-Ras before and after modification. Lanes 4 through 6 show a 
time course of the reaction of H-Ras with GSSG. After 1 minute reaction with GSSG (lane 
4), the reduced band (pi = 4.3) disappears and H-Ras migrates as two bands pis of 4.1 and 
4.0. These bands apparently result firom the complete modification of one cysteine and the 
partial modification of a second. By one hour (lane 6) at least two cysteines are completely 
modified and bands for modification of all four reactive cysteines are visible. If H-Ras is 
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Figure 2. Reaction of H-Ras with GSSG. 
H-Ras (10 nM) was incubated with 20 mM GSSG for the indicated times at 37°C 
and pH 8.0. The reactions were stopped by alkylation with lAM. The alkylation and 
reduction of the protein were performed as described in Figure IB. Lane 3 shows 
treatment with 10 mM lAM at pH 8.0 for 5 minutes before GSSG addition. 
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incubated with dithiothreitol after reaction with GSSG (lane 7), it niigrates as the untreated 
protein. This shows that the acidic bands are reductant-labile, another characteristic of S-
glutathiolated protein. If the protein is incubated with iodoacetamide previous to GSSG 
addition (lane 3), the reaction is blocked. 
If H-Ras is modifled with a positively charged adduct, the modified protein should 
focus with a more basic pi. Figure 3 shows that when H-Ras is incubated with the positively 
charged disulfide, cystamine (lanes 2,3), it niigrates at a more basic pi, marked "2" in the gel. 
The presence of a faint band at the position marked "I" suggests that there is one 
intermediate site in this reaction. The modified H-Ras can be returned to its original state by 
reduction with DTT (lane 4). This shows that H-Ras can be S-cystamylated on at least 2 
cysteine residues. 
H-Ras reactions with Hydrogen Peroxide. Since S-glutathiolation in cells probably occurs by 
direct oxidation of protein sulfhydryls (28), the reaction of H-Ras with H2O2 in the presence 
of 3 mM GSH was studied (Figure 4A). H-Ras was very rapidly modified on one site by 
H2O2 (lane 3) and this modification was DTT-reducible (lane 4). It is likely that this 
modification was S-glutathiolation. Lanes 5 and 6 show that 1.5 mM GSSG, the most which 
could possibly form in the reaction of 3.0 mM GSH and 2.0 mM H2O2, did not modify H-Ras 
to the extent seen in the H2O2 + GSH reaction. Thus, GSSG was not an intermediate in S-
glutathiolation of H-Ras in the H2O2 + GSH reaction. GSH was released from H-Ras and 
identified by coelution with GSH standards using anion exchange HPLC. S-glutathiolation 
calculated using HPLC (Figure 4B) is almost identical to the amount of S-glutathiolation as 
calculated firom the lEF gel (Figure 4A, lanes 3,4). Concentration of GSSG in this same 
reaction mixture was approximately 52 ^M. This means that 35% of the original GSH was 
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Figure 3. Reaction of H-Ras with Cystamine. 
H-Ras (10 ^M) was incubated with 5 mM cystamine for the indicated times at 
37°C and pH 8.0. The reactions were stopped by alkylation with lAM. The alkylation 
and reduction of the protein were performed as described in Figure IB. 
Figure 4. Reaction of H-Ras with Hydrogen Peroxide. 
A. H-Ras (10 ^M) was incubated with 2 mM H2O2 + 3 mM GSH (lanes 3,4) or 1.5 
mM GSSG (lanes 5,6) for 5 minutes at 37°C and pH 8.0. The reactions were stopped by 
alkylation with lAM. The alkylation and reduction of the protein were performed as 
described in Figure IB. B. An aliquot of H-Ras, incubated with H2O2 + GSH (±DTT) from 
part A (lanes 3,4), was assayed for release of GSH as described in Materials and Methods. 
The graph shows fractional modification (mole/mole) of H-Ras as calculated from lEF 
(described in Materials and Methods) and as determined by HPLC glutathione analysis. C. 
H-Ras (10 |xM) was incubated with 2 mM H2O2 ± 0.3 mM GSH at 37°C and pH 8.0. The 
reactions were stopped by alkylation with lAM. The alkylation and reduction of the protein 
were performed as described in Figure IB. lEF separation was performed as described in 
Materials and Methods. ModiHcation was determined by quantifying bands of the lEF 
separation. Reversible modiHcation is the difference in modification between DTT-untreated 
and DTT-treated lanes. Irreversible modification is modification in DTT-treated lanes minus 
the modification of untreated H-Ras protein. 
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oxidized to form GSSG. This suggests that the reactivity of one H-Ras cysteine is better than 
free GSH in this reaction. Figure 4C shows calculated irreversible and reversible 
modification of H-Ras in a reaction with H2O2. In the absence of GSH, less than 20% of one 
thiol is irreversibly oxidized even after 20 minutes, but as little as 0.3 mM GSH is necessary 
to cause S-glutathiolation of H-Ras on 75% of the protein (Figure 4C). Irreversible oxidation 
of H-Ras by H2O2 is not as rapid as S-glutathiolation. This has also been observed in studies 
of carbonic anhydrase III (see Chapter I). 
H-Ras reaction with S-nitrosoglutathione. S-nitrosylation has been increasingly recognized 
as an important oxidative modification of proteins (21,30-32). Pure H-Ras has been shown 
to react with NO on CysIlS in mutants that do not contain the c-terminal tail (truncated 
mutant) (6) and on at least three cysteines in extracts of E. coli which overexpress wildtype 
H-Ras (21). H-Ras may also react with NO in vivo as part of signal transduction processes 
(6). Figure 5 A, lanes 1-3 show H-Ras incubated with I AM after S-nitrosoglutathione 
incubation. Lane 2 shows that some S-glutathiolation occurs, since the protein appears about 
equally distributed between the reduced (pi = 4.3) and singly modified isoforms (pl = 4.1). 
This modification was reversible with DTT treatment (lane 3), Because S-nitrosylation is an 
uncharged modification of protein cysteine, H-Ras was reacted with lAA after S-
nitrosoglutathione incubation. S-nitrosylation causes the inhibition of lAA derivitization. 
When purified H-Ras was incubated with S-nitrosoglutathione, as many as three cysteines 
were S-nitrosylated, as indicated by inhibition of lAA reaction (lanes 4,5). S-nitrosylation is 
a reversible modification, so DTT treatment (lanes 6) reduced the S-nitrosylated H-Ras and 
restored the lAA-modified forms. When S-nitrosoglutathione was reacted with extracts of E. 
coli that overexpress C181S/C184S mutant H-Ras, nearly one full site was S-nitrosylated, 
Figure 5. Reaction of H-Ras witli S-nitrosoglutathione. 
A. H-Ras(10 |iiM) was incubated with 5 mM S-nitrosogiutathione for 5 minutes at 
37°C and pH 8.0. The reaction was stopped by alkylation with lAM (lanes 1,2) or lAA (lanes 
4,5) as described in Figure IB, The protein was reduced (lanes 3,6) as described in Figure 
IB and alkylated with either lAM (lane 3) or LAA (lane 6). B. lEF/Westem blot of extracts 
of E. coli that overexpress C181S/C184S mutant of H-Ras treated with S-nitrosoglutathione. 
E. coli overexpressing H-Ras were cultured and lysed as described in Materials and Methods. 
Extracts were then treated with 5 mM S-nitrosoglutathione for 15 minutes. The reaction was 
stopped with 25 mM lAM or 40 mM lAA at pH 7.5. DTT treatment was 10 mM for 15 
minutes followed by reaction with lAM or LAA, Extracts were then separated and visualized 
by lEFAVestem blot analysis as described in Materials and Methods. C. lEFAVestem blot of 
extracts of E. coli that overexpress the truncated mutant of H-Ras treated with S-
nitrosoglutathione. E. coli overexpressing H-Ras were cultured and lysed as described in 
Materials and Methods. Extracts were then treated with 5mM S-nitrosoglutathione for 15 
minutes. The reaction was stopped with 20 mM Cystamine at pH 7.5. DTT treatment was 10 
mM for 15 minutes followed by reaction with cystamine. Extracts were then separated and 
visualized by lEF/Westem blot analysis as described in Materials and Methods. 
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and again small amounts of S-glutathiolation occurred (Figure 5B). Cysl 18 was previously 
shown to be S-nitrosylated with authentic NO, However, lAA did not react with Cysl 18 
(Figure 1), so it was necessary to determine whether Cysl 18 would be S-nitrosylated by S-
nitrosoglutathione using the truncated mutant. Incubating extracts of E. coli that overexpress 
the truncated mutant H-Ras with cystamine (Figure 5C, lane 2) showed a shift in H-Ras 
migration to a more basic pi compared to NEM-treated H-Ras (lane 1). Thus, Cysl 18 was 
one of the sulfhydryls that reacted with cystamine. If the extract was incubated with S-
nitrosoglutathione before cystamine treatment (lane 3), the cystamine reaction was inhibited. 
This inhibition was removed by DTT incubation (lane 4). Thus it was found that S-
nitrosoglutathione reacts with H-Ras to form S-nitrosylated H-Ras on at least four cysteines 
and is S-glutathiolated on one cysteine. 
These experiments illustrate that in vitro, the cysteine residues of H-Ras will 
participate in a wide variety of thiol oxidations including S-glutathiolation, S-nitrosylation, 
and irreversible oxidation. 
S-thiolation of H-Ras in NIH-3T3 cells. The cysteines of H-Ras have individual functions in 
vivo. Lipids modify all three cysteines on the c-terminus of H-Ras; Cysl86 is prenylated, 
and Cysl81 and 184 are palmitoylated. The availability of these cysteine residues for 
oxidative modification in vivo is unknown. To address this question, NIH-3T3 cells 
overexpressing either wildtype (wt), CI 18S, or C181S/C184S H-Ras were oxidized with 
diamide. Diamide produces extensive and reversible S-thiolation in vivo (20,33). Figure 6 
shows the effects of several concentrations of diamide on total protein S-thiolation of WT, 
CI 18S, and C181S/C184S expressing cells. In all 3 cell types 2 mM diamide produces 
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Figure 6. S-thiolation of total cytosoHc proteins in cells overexpressing mutant 
forms of H-Ras by the thiol oxidant diamide. 
NIH-3T3 cells overexpressing wildtype and mutant forms of H-Ras were labeled 
with Tran^^S-label for 4 hours to achieve a specific activity of glutathione of 
approximately 5x10' cpm/^mol. Labeling was carried out in the presence of 
cycloheximide (100 ^g/ml) to prevent protein synthesis during glutathione labeling (38). 
Cells were treated with diamide for 10 minutes, lysed with 20 mM ^-glycerophosphate 
buffer containing 50 mM NEM, spun at 160,00 x g to remove insoluble proteins, and 
spotted on filter paper for processing. Filter squares were washed in 10% TCA to 
remove non-protein counts as described previously (38). Control samples were treated 
with 50 mM DTT for 30 minutes at 3TC before spotting on paper to determine 
background incorporation into proteins. S-thiolation is measured in nmols of GSH 
incorporated into proteins per mg total protein. 
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maximal S-thiolation, approximately 5 nmols adduct/mg of total cellular protein. 
Figure 7 shows an lEF gel of the reaction of pure H-Ras with diamide in the presence 
of GSH in vitro. Lane 3 shows that the reacted protein migrates at a pi indicating addition of 
two glutathione adducts (pi = 4.0). This modification is reversible with DTT (lane 4). This 
demonstrates that diamide will effectively cause S-glutathiolation of at least two sites on H-
Ras in vitro. 
To examine the extent of H-Ras S-thiolation in cells expressing various H-Ras 
proteins, H-Ras was immunoprecipitated from cells labeled with ^^S-cysteine. Figure 8 
shows an SDS-PAGE gel of H-Ras from cells overexpressing wildtype (lanes 1,2), CI 18S 
(lanes 3,4), or C181S/C184S (lanes 5,6) H-Ras. The top of the figure shows the Coomassie 
blue stained bands of the immunoprecipitated H-Ras and the bottom shows the 
autoradiograph of the radioactivity associated with the bands. Reduction sensitive 
radioactivity was associated with the H-Ras band from each of these cells (compare lanes 1, 
3, and 5 with lanes 2,4, and 6, respectively), indicating that H-Ras was S-thiolated under 
these conditions. WT H-Ras was not S-thiolated in untreated cells (not shown). This 
experiment demonstrates the potential for oxidative modification of H-Ras in cells. Since all 
three forms of the protein were glutathiolated, neither Cysl 18, Cysl81 nor Cysl84 is 
necessary for S-glutathiolation of the protein. Cysl86 may be the primary site of S-thiolation 
in vivo. 
Discussion 
From this data it is possible to propose the model shown in Figure 9. Based on 
mutational analysis, H-Ras reacts with negatively charged lAA on three sites, Cysl81, 
Cysl84, and Cysl86. Of the six cysteine residues on H-Ras, four, cysteines 118, 181,184, 
63 
Diamide 
+ 
lAM lAA 3mMGSH 
+ DTT 
Lane 
Figure 7. Reaction of H-Ras witii Diamide. 
H-Ras (10 ^iM) was incubated with 2 mM diamide + 3 mM GSH for 5 minutes at 
37°C and pH 8.0(lanes 3,4). The reaction was stopped with lAM (lane3) or by reduction 
with DTT and then alkylation with lAM (lane 4). Alkyiations and reduction were 
performed as described in Figure IB. 
Figure 8. S-thiolation of Mildtype and cysteine mutants of H-Ras in NIH-3T3 cells 
treated with diamide. 
Cells overexpressing WT, C118S, orC181S/Cl84S H-Ras were labeled with 
Tran"S-label for 4 hours in the presence of cycloheximide (100 |ig/ml), then treated with 2 
mM diamide for 10 minutes. Cells were then washed twice with ice cold PBS and lysed with 
immunoprecipitation buffer (TBS/1% uiton x-100/0.5% Sodium Deoxycholate/0.1% SDS) 
containing SO mM NEM to stop artifactual modification of proteins. Lysates were 
centrifuged at 15,000 x g and H-Ras was immunoprecipitated from cellular lysates with 
agarose-conjugated Ab-1. The supernatant was then incubated at 4°C with the 
immunoprecipitation beads for 2 hours. Then the inununoprecipitation beads were washed 
twice in immunoprecipitation buffer and layered over immunoprecipitation buffer + 7.5% 
sucrose twice. Approximately 5 |il of beads were used per 0.5 mg total protein to yield 0.1-
0.2 |ig of H-Ras. H-Ras was released from the immunoprecipitation beads by boiling for 5 
minutes in SDS-PAGE sample buffer containing 10 mM NEM. Replicate lanes were treated 
with 10 mM DTT before NEM treatment to release reduction-sensitive radioactivity. Gels 
were stained with Coomassie blue, dried and exposed to film. Both radioactive and 
Coomassie blue-stained bands were quantified using densitometry to determine radioactivity 
relative to the protein stain. Ratios are normalized to the background incorporation after 
DTT treatment. 
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Figure 9. Model for reactivity of sulfhydryls of H-Ras. 
The S-nitrosylation (S-NO) and modincation of cysteines by lAA (S-AA ) were 
positively identified by mutational analysis of reactivity. S-cystamylation of Cysl 18 
(SSCystam^) was identified by mutational analysis of reactivity. S-cystamylation of 
CyslSl was inferred by reactivity of cystamine with up to two sites and by analysis of 
the H-Ras sequence; reactivity with Cysl84 or Cysl86 is also possible. S-
glutathiolation of CysISl and 186 (S-SG") was inferred by reactivity with two sites, 
reactivity with lAA, electrostatic analysis, and analysis of the H-Ras sequence. Trace S-
glutathiolation on two additional sites was observed in lEF gels. 
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and 186, are likely to be surface exposed as shown by structural, chemical, and mutational 
studies (8,10,27). Figure IDA shows an electrostatic surface calculation of the area on H-Ras 
surrounding Cysl 18. While the sulfur atom appears to be surface accessible, it resides within 
a region of negative charge. On this basis, Cysl 18 should not react with negatively charged 
lAA. 
Positively charged cystamine does react with Cysl 18. It is likely that the negative 
charge environment around Cysl 18 enhances this reaction. While the structure of the c-
terminal cysteines is not available for analysis, the sequence is available (Figure 9B). It is 
reasonable to suggest that lysl8S, which carries a positive charge at physiological pH, can 
affect the charge environment of cysteines 184 and 186 enough to inhibit reactions with 
positively charged reagents. Thus, it is most likely that Cysl81 is the second cysteine that 
reacts with cystamine. 
H-Ras can be readily S-glutathiolated on at least two sites. lAA, which also carries a 
negative charge, reacts with three cysteine residues. Since lAA does not react with Cysl 18, 
it is likely that GSH will also not react at that site. It is therefore probable that the c-terminal 
cysteines are S-glutathiolated. Lysl85 may enhance reactivity of Cysl84 and Cysl86, 
however, steric interference may prevent simultaneous formation of adducts at both Cysl84 
and 186. This may explain the differences in reactivity of lAA and S-glutathiolating agents. 
Therefore Cysl81 and either Cysl84 or Cysl86 are likely the two residues which are S-
glutathiolated, based on the reactivity of similarly charged lAA, the electrostatic surface 
map, and the steric considerations discussed above. 
In contrast to S-glutathiolation, the S-nitrosylating agent S-nitrosoglutathione readily 
modiHed all four available cysteine residues in vitro (Figure 5). This data suggests that 
Figure 10. Environment of H-Ras Cysteine residues. 
A. A stereo diagram shows an electrostatic surface calculation of the area 
surrounding CysllS. The X-ray crystal structure of H-Ras (PDB Accession code 12 IP) was 
used in electrostatic surface charge calculations with MolMol (34). The sulfur atom of 
CysllS is labeled. Positively charged areas are black, neutral regions are white and 
negatively charged regions are grey. The positive region nearest Cysl IS is marked with a 
"+" while the nearest negative region is highlighted with a B. The sequence of amino 
acids surrounding CyslSl, 1S4, and 1S6. The sequence was obtained from GenBank 
(#NM_005343). 
^sll8 
€ys 118 
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S-nitrosylation is a very non-specific reaction, dependent perhaps only on the nucleophilic 
character and surface exposure of the thiol in question. Further experiments may clarify this 
question in intact cells. 
The in vivo data (Figure 8) suggests that while cysteines 118, 181, and 184 may be S-
glutathiolated in cells, none of them are required for S-thiolation. This agrees with in vitro 
data that diamide and GSH modify multiple thiols (Figure 7). Because cycloheximide 
treatment and the overexpression of different mutants of H-ras may alter membrane 
association of H-Ras (11), and thus, availability of cysteines 181, 184 and 186, direct 
comparisons of relative reactivity may not be possible between the different mutants. 
We can hypothesize that specificity for a particular adduct on a particular site can be 
achieved through the charge environment of that site. An uncharged adduct such as NO 
would be equally likely to modify positively and negatively charged sites, while a negatively 
charged adduct like glutathione would preferentially react with positively charged sites. 
Because many cysteine sulfurs are thought to create a negative charge environment (35), a 
site with a positive charge would potentially be highly favored in vivo when competing with 
protein sulfhydryls for available GSH. The charge environment may be changed 
significantly by the addition of glutathione, providing a potential mechanism for allosteric 
effects. 
In reactions of cysteines with H2O2, the formation of a charged adduct such as the 
sulfinic acid is a two-step reaction, with sulfenic acid as the intermediate. In the presence of 
GSH, the predominant form of oxidized cysteine is the S-glutathiolated cysteine. This 
provides the obvious advantage over irreversible oxidation in that the S-glutathiolated 
cysteine is reducible by thiol-disulfide exchange. This means that regulation by this 
mechanism can be reversible (36,37). It is also possible that the size and charge 
characteristics of the glutathione might allow recognition by a protein in addition to possible 
allosteric changes associated with the adduct. 
Because negatively charged lAA does not react with CysllS, this site is probably not 
S-giutathiolated efficiently, and regulation at this site by S-glutathiolation is not likely in H-
Ras, S-nitrosylation of this site in vitro has been confirmed (6,21) and this site may still be 
regulated by S-nitrosylation in vivo. However, the oxidation of the c-terminal cysteine 
residues is likely in vivo, which means that lipidation may be regulated by oxidation in vivo 
through S-glutathiolation in cells under oxidative stress, or through S-nitrosylation in cells 
under nitrosative stress. Whether this regulation would be occur by direct inhibition of 
lipidation or through a more complex mechanism is uncertain. If the lipidation sites and 
Cysl 18 are modified oxidatively or nitrosatively in vivo, then regulation through these 
mechanisms could be concentration and/or time dependent. The total activity of H-Ras 
would be the sum total of the negative regulation by inhibition of lipidation (10,11) and the 
positive regulation of CysllS allosteric effects (6). 
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CHAPTER ni: 
S-NITROSYLATION AND S-GLUTATfflOLATION OF H-RAS 
IN VIVO BY S-NITROSOCYSTEINE 
A paper to be submitted to Archives of Biochemistry and Biophysics 
Robert J, Mallis and James A. Thomas 
Abstract 
The effect of S-nitrosocysteine on cells has been attributed primarily to protein S-
nitrosylation. In this report the effect of S-nitrosocysteine on protein S-nitrosylation and S-
glutathiolation of the low molecular weight G-protein H-Ras in NIH-3T3 cells is studied. S-
nitrosocysteine caused the formation of S-nitrosoglutathione, cysteine-glutathione disulfide, 
cysteine, cystine, and glutathione disulfide in NIH/3T3 cells. Additionally, it was found that 
S-nitrosocysteine caused S-nitrosylation, S-glutathiolation and S-cysteylation of the cytosolic 
protein pool. S-nitrosylation was the dominant modification, but S-glutathiolation and S-
cysteylation accounted for approximately 10-20% of the total protein thiol modification. H-
Ras, immunoprecipitated firom NIH-3T3 cells overexpressing wildtype H-Ras (NIH-
3T3/WT) and treated with 1 mM S-nitrosocysteine, was found to contain approximately 0.85 
moles S-nitrosocysteine per mole of H-Ras protein as determined by nitrite release from the 
protein. In a similar experiment, H-Ras was immunoprecipitated from NIH-3T3/WT cells in 
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which the glutathione pool was radiolabeled with ^^S-cysteine. S-nitrosocysteine (1 mM) 
caused formation of approximately 0.16 moles S-glutathiolated protein cysteine per mole H-
Ras as determined by release of protein bound radioactivity by dithiothreitol. These results 
suggest that both S-nitrosylation and S-glutathiolation can regulate H-Ras. These results also 
suggest that S-nitrosocysteine enters cells intact, modifying both protein and low molecular 
weight thiols by a variety of reactions. S-nitrosylation may be an important but not unique 
modification of H-Ras that results firom an extracellular S-nitrosocysteine pool. 
Introduction 
H-Ras, a low molecular weight G-protein, is an integral component of the 
extracellular signal-regulated kinase (Erk)' pathway (1). H-Ras is necessary for the 
activation of this pathway by reactive oxygen species such as hydrogen peroxide (H2O2) and 
nitric oxide (NO) (2-5). Pure H-Ras can be S-nitrosylated on as many as four cysteine 
residues (see Chapter II) in vitro by the NO-donating compound S-nitrosoglutathione or on at 
least one cysteine by NO (7). This data has led to speculation that S-nitrosylation of H-Ras 
can be a mechanism for activation the Erk pathway in vivo (7). Our recent work has also 
shown that H-Ras can be S-thiolated, i.e. oxidized to form a protein-thiol mixed disulfide, in 
vitro and in vivo by thiol oxidants including H2O2, diamide, and glutathione disulHde 
' Abbreviations used in this paper: DTT, dithiothreitol; Erk, extracellular signal-regulated kinase; 
GSH, reduced glutathione; GSSG, glutathione disulfide; lAA, iodoacetic acid; lAM, iodoacetamide; lEF, 
isoelectric focusing; NEM, N-ethylmaleimide. 
77 
(GSSG)^ (see Chapter II). This raises the possibility that the Erk pathway can also be 
regulated by S-thiolation of critical cysteine residues of H-Ras. 
NO and its related compounds are thought to regulate diverse processes in vivo, 
including vasodilation (8), platelet aggregation (9), apoptosis (10,11), and cell proliferation 
(7). Although NO regulates vasodilation by stimulating guanylate cyclase to form cyclic 
guanosine monophosphate (cGMP) (8), the mechanisms for regulation of other processes are 
less well understood. A class of NO-related compounds that may be responsible for some of 
its biological activity is the S-nitrosothiol. The mechanism of synthesis of S-nitrosothiols in 
vivo is the subject of considerable research (12-16). S-nitrosothiols have been found in low 
micromolar concentrations in various tissues and the possibility for higher concentrations 
exists in situations such as induction of nitric oxide synthase enzymes either within cells or 
during the respiratory burst of immune cells (17). S-nitrosothiols may be NO-carriers in the 
induction of vasodilation (17,18) and may also be integral in regulation of platelet 
aggregation (9). NO regulation of many processes may be mediated by the formation of S-
nitrosothiols on critical protein sites. S-nitrosylation of a protein can affect the activity of 
that protein either through direct inhibition of the active site, as shown in vitro with 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (19) and caspase (10,11), or through 
allosteric effects, as is suggested with H-Ras (7). 
^ A note on nomenclature: GSH refers ONLY to the reduced form of glutathione. GSSG refers only to 
glutathione disulfide. Oxidized glutathione may refer to several forms of glutathione including GSSG, cysteine-
glutathione disulfide, S-glutathiolated protein and S-nitrosogiutathione. 
The addition of S-nitrosothiols to mixtures of thiols in vitro initiates two main 
phenomena. First, NO^ is transferred very rapidly from the S-nitrosothiol to free thiols until 
thermodynamic equilibrium is achieved (20). If thiols are in excess of the S-nitrosothiols, 
then near quantitative transfer of the NO^ to the thiols will be achieved (20). This applies to 
both protein thiols and low molecular weight thiols, including reduced glutathione (GSH) 
and cysteine (20,21). The second phenomenon that occurs when S-nitrosothiols are mixed 
with thiols is the degradation of the S-nitrosothioI to its disulfide and nitrite over time. This 
multistep process is accelerated by the presence of free thiols (21,22), is accelcrated by 
oxygen (22), and occurs more slowly than transnitrosation reactions (20,21,22). 
In cells, the fate of S-nitrosothiols is uncertain. GSH and protein cysteine 
concentrations are very high in cells. At low concentrations of S-nitrosothiol, transfer of 
NO*^ to endogenous thiols may be nearly quantitative if breakdown of the S-nitrosothiol does 
not occur by other mechanisms first (20,22). The consequences of this would be S-
nitrosylation of GSH and protein cysteines. Breakdown of an S-nitrosothiol before it enters 
the cells, or breakdown of S-nitrosothiols within the cell might produce a variety of reaction 
products (22). These possible products include disulfides, including protein-glutathione 
mixed disulfides (S-glutathiolated proteins) as well as disulfides of the original donor, 
sulfinic and sulfonic acids, nitrite, nitrous oxide, and ammonia (22,23). Additionally, 
interactions with other reactive oxygen species such as superoxide might lead to still more 
complex reactions (24,25). These studies suggest that S-nitrosylation of proteins is a likely 
outcome of addition of S-nitrosothiols to cells, however, other oxidations including S-
glutathiolation of proteins are possible. S-glutathiolation of a protein cysteine residue could 
have effects similar to S-nitrosylation if formation of an adduct inhibits chemical reactivity 
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of that cysteine. However, if allosteric effects or effects on protein-protein interactions are 
thought to occur, then S-nitrosylation and S-glutathiolation might have different 
consequences. 
In this paper, we study the reactions between S-nitrosocysteine and endogenous thiols 
in NIH-3T3 cells. The effects of S-niu-osocysteine on low molecular weight thiols, total 
protein thiols and H-Ras were determined. Data presented here shows that S-nitrosocysteine 
causes significant oxidation and S-nitrosylation of the low molecular weight thiols as well as 
S-nitrosylation, S-glutathiolation, and S-cysteylation of total protein thiols. H-Ras is found 
to be both S-nitrosylated and S-glutathiolated under these conditions. 
Materials and Methods 
Materials. 1-cysteine, d-cysteine, Dithiothreitol (DTT), reduced glutathione (GSH), 
glutathione disulHde (GSSG), iodoacetic acid (lAA), iodoacetamide (lAM), N-
acetylpenicillamine, N-ethylmaleimide (NEM), and rat anti-mouse alkaline phosphatase-
conjugated antibody were from Sigma, Inc (St. Louis, MO). Cell culture reagents were 
purchased from GIBCO-BRL (Gaithersburg, MD), with the exception of bovine calf serum 
(BCS) which was from HyClone (Logan, UT). Ampholytes were purchased from 
Amersham-Pharmacia (Piscataway, NJ). Agarose conjugated Ab-l and recombinant human 
H-Ras were purchased from Calbiochem-Novabiochem (San Diego, CA). Monoclonal Ab 
146-03E4 (Ab 146) was purchased from Quality Biotech (Camden, NJ). 2,3-
diaminonaphthalene (DAN) was purchased from ICN Pharmaceuticals, Inc (Costa Mesa, 
CA). 
Cell Culture. NIH-3T3 fibroblasts were obtained from American Type Culture 
Collection (ATCC) and cultured according to their recommendations (Dulbecco's Modified 
Eagle Medium (DMEM) + 2mM Glutamine + 0.2mM Sodium Pyruvate + 10% BCS + 100 
units/ml each of Penicillin and Streptomycin). NIH-3T3 cells overexpressing wildtype H-
Ras were a generous gift firom L.A. Quilliam (Indiana University School of Medicine, 
Indianapolis, IN) and were cultured according to ATCC recommendations for NIH-3T3 cells. 
Preparation of S-nitrosothiols. S-nitrosocysteine and S-nitrosoglutathione were 
prepared as previously described (6). Briefly, 220 ^il each of 220 mM GSH and 220 mM 
sodium nitrite were mixed with 25 ^il of 4.0 N HCl and incubated in the dark at room 
temperature for 10 minutes. The solution was then neutralized with 25 |il of 4.0 N NaOH to 
give a final concentration of approximately 100 mM S-nitrosoglutathione. The final 
concentration was calculated from absorbance at 334 nm using the extinction coefficient 767 
M"' cm"' (26). S-nitroso-N-acetylpenicillamine was prepared as described (27). Briefly, 50 
mg N-acetylpenicillamine was dissolved in 600 |il methanol + 120 ^1 IN NaOH on ice. 
Sodium Nitrite (155 mg) was dissolved in 100 |il doubly distilled HjO and added to the first 
solution. This solution was then acidified with 360 ml concentrated HCl to a pH of 1. The 
solution was then vortexed and left on ice. The resulting green solid precipitate was 
centrifuged at 15,000 x g and the pellet was washed three times with ice cold doubly distilled 
H2O and dried in a vacuum. The resulting green solid was stored at -20°C. The dried solid 
was dissolved in PBS + 0.04 N NaOH and neutralized using 40 ml of I N HCl before 
addition to cultures. The concentration of S-nitroso-N-acetylpenicillamine was calculated 
using the absorbance at 338 nm and the extinction coefficient 890 M*'cm'' (28). 
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Cellular experiments. NIH-3T3 cells were grown to confluence (assessed visually, 
approximately 1-2 x 10^ cells/35 mm plate) and the medium was changed. Experiments were 
started 24 hours later. Experiments were conducted in phosphate buffered saline (PBS) to 
avoid any oxidative artifacts associated with interactions between DMEM and added 
oxidants. PBS was added to cells 5 minutes prior to the addition of oxidant to avoid 
oxidative artifacts associated with change of medium. 
Anion Exchange HPLC Analysis of Low Molecular Weight Thiols. Low molecular 
weight thiols were analyzed as described by Fariss and Reed (29) with some modifications. 
Briefly, 20 ^l of 1.3 M iodoacetic acid (lAA) was added to the 200 |il sample to a final 
concentration of 120 mM and the pH was raised to ~8.5 by addition of dry potassium 
bicarbonate. An equal volume of fluorodinitrobenzene (FDNB) in 100% ethanol was added 
to a final concentration of 0.5% and incubated overnight at 4°C. Samples were separated on 
an aminopropyl anion exchange column (CEL Associates, Inc. Houston, TX). All thiol 
compounds were identified by coelution with standards. S-nitrosoglutathione and disulfides 
were also identified by susceptibility to reduction with dithiothreitol (DTT). All compounds 
were previously identified with this methodology (6,29). 
Analysis of Cellular Low Molecular weight thiols. NIH-3T3 cells were rinsed twice 
with ice cold PBS and lysed with 10% perchloric acid. Plates were scraped and the soluble 
and precipitated materials were collected and stored at -20°C for <1 week. To remove 
precipitated proteins, samples were centrifiiged at ~15,000 x g for 10 minutes. A fraction 
(200 ^1) of the supernatant was used for the HPLC analysis of low molecular weight thiols 
while the pellet was stored at -20°C for < 1 week for subsequent protein assay. 
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Protein assay. Protein concentration was determined as described by Lowry et al 
(30). 
S-nitrosylated protein assay. Total protein nitrosothiol concentration was determined 
by first lysing cells with hypotonic buffer (20 mM P-glycerophosphate buffer pH 7.4 
containing 50 mM NEM). Then lysates were centrifuged at 15,000 x g for 30 minutes and 
the soluble material was dialyzed for 5 days at 4°C against 20 mM P-giycerophosphate buffer 
pH 7.4. Dialyzed samples were analyzed for mercuric chloride-releasable nitrite by the 
methodology of Kostka and Park (31). Nitrite and S-nitrosoglutathione standards were 
prepared within 2 hours of the assay. 
Total S-thiolated protein assay. Total S-thiolated protein was determined as 
described by Fariss and Reed (29). Briefly, treated cells were lysed with hypotonic buffer 
(20 mM P-glycerophosphate buffer pH 7.4 containing 50 mM NEM). Lysates were 
centrifuged at 15,000 x g for 30 minutes. Soluble proteins were then precipitated by adding 
70% perchloric acid to a Hnal concentration of 10%. After centrifugation, the supernatant 
was discarded and the pellet was washed with ice-cold 100% ethanol. The pellet was then 
resuspended in MOPS buffer + DTT or MOPS buffer alone and incubated for 60 minutes at 
37°C. 70% perchloric acid was again added to a final concentration of 10% and the sample 
was centrifuged at 15,000 x g. The supernatant was recovered and released cysteine and 
GSH were analyzed by anion exchange HPLC as described above. 
Isoelectric focusing (lEF) ofphosphorylase b. Purified phosphorylase b was 
separated on horizontal slab gels (5.0% acrylamidey2.7%Bis-acrylamide/0.3% ampholyte pH 
4.0-6.0/1.7% ampholyte pH 5.0-8.0) at 1500V and 1.1 watt/cm for 50 minutes (6). 
Approximately 1 ^g of protein was applied to each lane. 
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Specific activity of cellular glutathione. Cells labeled with Tran^^S-label (ICN 
Pharmaceuticals, Inc., Costa Mesa, CA) were lysed and treated as above for analysis of low 
molecular weight thiols. Samples were prepared for anion exchange HPLC analysis of low 
molecular weight thiols as described. The GSH and GSSG peaks were collected and counted 
using a Beckman LS-IOOC scintillation counter. 
Immunoprecipitation ofH-Ras. H-Ras was inununoprecipitated from cellular lysates 
of NIH-3T3 cells overexpressing H-Ras using agarose-conjugated Ab-1. The agarose-
conjugated Ab-1 was washed once with immunoprecipitation buffer (TBS/1% triton X-
100/0.5% Sodium Deoxycholate/0.1% SDS) before adding to cellular lysates. The cells were 
washed twice with ice cold PBS and lysed with immunoprecipitation buffer containing 50 
mM NEM. Lysates were centrifiiged at 15,000 x g and the supernatant was incubated at 4°C 
with the agarose-conjugated Ab-1 for 2 hours. The agarose-conjugated Ab-1 was then 
washed twice in immunoprecipitation buffer and then layered over immunoprecipitation 
buffer + 7.5% sucrose twice. Approximately 5 |J,1 of agarose-conjugated Ab-1 was used per 
0.5 mg total protein to yield 0.1-0.2 ^ig of H-Ras, 
Western Blot Analysis of H-Ras. H-Ras was separated by SDS-PAGE as previously 
described (32) and transferred to Inunobilon-P (PVDF) (Millipore, Inc, Bedford, MA) 
membrane using a Bio-Rad Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad Laboratories, 
Hercules, CA) according to the recommendation of the manufacturer. H-Ras was visualized 
with Ab 146 primary antibody (1:3,000 dilution) and rat antimouse alkaline phosphatase 
secondary Ab (1:10,000). Bands were detected with p-nitroblue tetrazolium chloride 
(NBT)/5-bromo-4-chloro-3-indoyl phosphate (BCIP). 
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Assay of S-glutathiolated H-Ras. S-glutathiolation of H-Ras was determined using a 
modiflcation of previously described methods (29). H-Ras was immunoprecipitated from 
cellular lysates as described above. The washes from the inununoprecipitation procedure 
were counted by liquid scintillation and one extra wash in inmiunoprecipitation buffer was 
added to bring unbound counts to background levels. H-Ras bound to agarose-conjugated 
Ab-I was then precipitated by adding 70% perchloric acid to a final concentration of 10%. 
After centrifugation, the supernatant was discarded and the pellet was washed with ice-cold 
100% ethanol. The pellet was then resuspended in MOPS buffer + DTT or MOPS buffer 
alone and incubated for 60 minutes at 37°C. 70% perchloric acid was again added to a fmal 
concentration of 10% and the sample was centrifiiged at 15,000 x g. The supernatant was 
recovered and released radioactivity was counted by liquid scintillation. The radioactive 
counts of samples not treated with DTT were subtracted from the counts of samples treated 
with DTT to determine reduction sensitive counts. This number was divided by the specific 
activity of GSH to calculate the amount of S-glutathiolated protein. An aliquot of each 
experimental treatment was separated by SDS-PAGE as described (32) and transferred 
membrane for western blot analysis as described above The protein content of each assay 
was calculated from the SDS-PAGE/Westem Blot by comparison with a dilution series on 
the same gel (not shown). When the membrane was exposed to film for 1 day or 5 days, the 
radioactivity associated with the protein allowed us to assess the purity of the 
inununoprecipitate as greater than 95% because no bands other than H-Ras were seen on the 
film. 
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Results: 
S-nitrosocysteine causes S-nitrosylation and S-thiolation of low molecular weight thiols in 
NIH-3T3 cells. In order to study S-thiolation and S-nitrosylation in cells, it was important to 
measure S-nitrosothiols and oxidized thiols simultaneously. Figure 1A shows the anion 
exchange HPLC analysis of the low molecular weight thiols of NIH-3T3 cells. GSH was the 
most abundant thiol present in these cell lysates. The concentration of cysteine, the next 
most abundant thiol, was approximately 10-fold lower than that of GSH. Several peaks 
appeared after adding ImM S-nitrosocysteine for 3 minutes (Figure IB). The new peaks 
were identified as described in the figure legend. Subsequent experiments in which the 
cellular thiols were labeled with ^^S-cysteine (Figure 11) confirmed that all of the identified 
peaks were sulfur-containing compounds. The peaks for S-nitrosoglutathione, cystine and 
glutamate did not bind tightly to the column and were difficult to separate due to spreading of 
their peaks. Because of this, the sensitivity of the assay of S-nitrosoglutathione and cystine 
materials was diminished. S-nitrosocysteine could not be measured by this methodology. 
The S-nitrosoglutathione peak is evidence of S-nitrosylation of intracellular GSH. Increases 
in GSSG, cystine and cysteine-glutathione disulfide indicate that S-nitrosocysteine treatment 
led to formation of disulfides at the same time. Increases in intracellular total cysteine 
(cysteine + cystine + cysteine-glutathione disulfide) suggest that S-nitrosocysteine and not 
just the NO moiety entered the cell. 
Figure 2A shows the time course of S-nitrosylation of GSH and the oxidation of the 
low molecular weight thiol pool by I mM S-nitrosocysteine. Intracellular S-
nitrosoglutathione, GSSG, and cystine increased rapidly, reaching a maximum by 3 minutes 
and remained above background levels for greater than 60 minutes. GSH decreased, 
Figure 1. HPLC Analysis of low molecular weight thiol pool of NIH-3T3 cells with S-
nitrosocysteine addition. 
NIH-3T3 cells were treated with ImM S-nitrosocysteine for 3 minutes, washed twice 
with ice cold PBS and lysed with 10% perchloric acid. The lysate was analyzed with anion 
exchange HPLC using the procedure of Fariss and Reed (29) modifled for analysis of 
cystine, S-nitrosoglutathione, cysteine, cysteine-glutathione disulfide, GSH and GSSG as 
described in Materials and Methods. Compounds were identiHed by retention time, which 
was confirmed by HPLC analysis of the pure compounds. The peaks isolated from cells that 
coeluted with S-nitrosoglutathione, cystine, cysteine-glutathione disulfide and GSSG were 
reduced with DTT treatment. A. Lysate of untreated cells. B. Lysate of cells treated with 
ImM S-nitrosocysteine for 3 minutes. 
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Figure 2. Time course of low molecular weight thiol changes in NIH-3T3 cells after S-
nitrosocysteine addition. 
A. Cells were incubated in 1 mM S-nitrosocysteine and lysed at the indicated times. 
Low molecular weight thiols were analyzed by anion exchange HPLC as described in 
Materials and Methods. Non-standard abbreviations: GSNO, S-nitrosoglutathione; CSSG, 
cysteine-glutathione disulfide. B. Time dependent changes in total glutathione and total 
cysteine from part A. Total glutathione = GSSG + cysteine-glutathione disulfide + S-
nitrosoglutathione + GSH. Total cysteine = cystine + cysteine-glutathione disulfide + 
cysteine. 
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rapidlyreaching its lowest point by 3 minutes and returning to pretreatment levels by 60 
minutes. Cysteine-glutathione disulfide increased more slowly until 10 minutes while 
cysteine reached its maximal levels very rapidly (1 minute). Total glutathione levels 
(including GSH, GSSG, cysteine-glutathione disulfide, and S-nitrosoglutathione) remained 
relatively constant after S-nitrosocysteine addition (Figure 2B). In contrast, total cysteine 
(cysteine, cystine, and cysteine-glutathione disulfide) increased by more than lO-fold within 
1 minute of S-nitrosocysteine addition. Total cysteine remained well above normal levels for 
more than 60 minutes. This kinetic analysis demonstrates that S-nitrosocysteine action is 
very rapid in cells producing significant changes in a variety of important compounds. 
Increased concentrations of oxidized forms of glutathione are indicative of 
intracellular oxidative stress. Figure 3 shows the rate of change in the oxidation of the total 
glutathione and cysteine pools in NIH-3T3 cells with 1 mM S-nitrosocysteine. Figure 3 A 
summarizes effects on glutathione-containing molecules. In Figure 3A, the ratio of 
GSSG/(GSSG + GSH) is highlighted with a dotted line, since this ratio is frequently used to 
express the oxidation state of the total glutathione pool. A maximum of 20% of the total 
glutathione would be GSSG by this assessment. However, major amounts of the total 
glutathione are also present as cysteine-glutathione disulfide. If cysteine-glutathione 
disulfide is examined as a fraction of total glutathione (GSSG + cysteine-glutathione 
disuinde + GSH), it is clear that 20% of the total glutathione is still in the oxidized form even 
at 30 minutes after treatment. The physiological role of cysteine-glutathione disulfide has 
not been studied in cells, but it is obvious here that it is contributing significantly to the 
oxidation state of the glutathione pool. The time course of cysteine-glutathione disulfide 
formation indicates that it forms slightly later than the other oxidized compounds, that its 
Figure 3. Time dependent changes in ratios of oxidized thiols with S-nitrosocysteine 
addition. 
Fractions of oxidized thiols in NIH-3T3 cells caused by S-nitrosocysteine were 
calculated from data in Figure 2A. Non-standard abbreviations; GSNO, S-
nitrosoglutathione; CSSG, cysteine-glutathione disulfide. A. Time dependent changes in 
disuinde formation of glutathione with S-nitrosocysteine addition. B. Time dependent 
changes in oxidation, including S-nitrosylation, of glutathione. C. Time dependent changes 
in disulfide formation of cysteine with S-nitrosocysteine addition. 
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breakdown is less efficient than other compounds, or both. Cysteine-glutathione disulfide 
may be the product of the reduction of S-glutathiolated proteins by cysteine or of S-
cysteylated proteins by glutathione. It may be broken down by participating in S-
glutathiolation and S-cysteylation of protein sulfhydryls by thiol-disulfide exchange. 
Glutathione reductase may also reduce cysteine-glutathione disulfide, but it is possible that 
the kinetics of this reduction are different than the kinetics of reduction of GSSG by 
glutathione reductase. These factors may all contribute to the differences in time dependence 
between cysteine-glutathione disulfide and the other oxidized compounds. 
In Figure 3B, the contribution of S-nitrosoglutathione to the total glutathione pool is 
analyzed. At the early times, S-nitrosoglutathione can account for about 50% of the total 
glutathione (GSSG + cysteine-glutathione disulfide + S-nitrosoglutathione + GSH) in the 
cells (Figure 3B). The other curve assesses the contribution of the total oxidized forms and it 
is clear that other oxidized thiols (i.e. disulfides) form the bulk of oxidized glutathione at 30 
minutes and 60 minutes. Thus, S-NO bonds are more abundant early and disulfide bonds are 
more important late in the process. 
The influx of cysteine with S-nitrosocysteine addition to cells suggests that the 
oxidation state of the cysteine pool might be important (Figure 3C). Cystine was the more 
important of the two oxidized forms at early times and cysteine-glutathione disulfide became 
a more significant firaction at 10,30 and 60 minutes. Cysteine-glutathione disulfide therefore 
contributes significantly to the oxidation state of both the total glutathione and cysteine 
pools. 
Table I shows the effect of the concentration of S-nitrosocysteine on changes in cellular thiol 
pools. The amount of total cysteine in the cells (cysteine + cystine + cysteine-glutathione 
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Table I 
Effect of S-nitrosocysteine concentration on low molecular weight thiols 
in NIH-3T3 ceUs. 
S-nitrosocysteine was added to NIH-3T3 cell cultures in three different 
concentrations and low molecular weight thiols were analyzed by anion 
exchange HPLC as described in Materials and Methods. Data are 
reported in units of nmol/mg total protein. 
Cone. time cysteine cystine CSSG GSNO GSH GSSG 
(mM) (min) (nmol/mg) (nmol/mg) (nmol/mg) (nmol/mg) (nmol/mg) (nmol/mg) 
— 0 0.6±0.2 <0.1 0.4±0.3 <0.1 27±4 1.3±0.2 
0.1 10 7.4±0.2 <0.1 0.91:0.1 0.3±0.6 27±2 0.75±0.15 
30 5.1±0.3 <0.1 0.7±0.1 <0.1 25±2 0.74±0.11 
60 3.6±0.2 0.5±0.9 0.6±0.l 0.2±0.4 30±2 0.87±0.13 
1 10 8.9±0.7 4.9±0.2 5.6±0.1 5.7±0.4 7.7±0.3 0.941:0.08 
30 8.atl.4 3.2±0.7 4.5±0.7 2.5±0.4 12±2 0.49±0.10 
60 4.0±0.3 l.2±0.3 2.5±0.2 2.2±0.l 21±2 0.791:0.08 
10 10 0.6±0.5 75±4 13±1 <0.1 3±2 0.23±0.05 
30 0.9±0.2 I13±9 13±1 <0.1 2±2 0.20±0.07 
60 0.6±0.3 14atl0 12±3 <0.1 7±2 <0.1 
disulfide) rose dramatically with concentration. At low S-nitrosocysteine, this pool was 
mostly reduced, while at high S-nitrosocysteine concentrations, it was completely oxidized to 
the disuinde. Cysteine-glutathione disulfide rose significantly after S-nitrosocysteine 
addition at all concentrations. S-nitrosoglutathione concentration was highest with 1 mM S-
nitrosocysteine. At high S-nitrosocysteine concentration, the total glutathione pool was 
significantly depleted and what remained was primarily cysteine-glutathione disulfide. 
Because different cell types contain variable amounts of soluble thiols (33), the effect of S-
nitrosocysteine on primary hepatocytes was studied. Hepatocytes contain approximately four 
times the amount of total glutathione that is found in NIH-3T3 cells. Figure 4A shows 
increases in intracellular S-nitrosoglutathione, cysteine, and cysteine-glutathione disulfide 
with S-nitrosocysteine addition. GSH concentration was approximately 120 nmol/mg protein 
and was essentially unchanged in this experiment. S-niU:osocysteine had a similar effect to 
that seen in NIH-3T3 cells, but the changes lasted for a shorter time. Changes in total 
glutathione (Figure 4B) were much smaller than those in NIH-3T3 cells. Total cysteine 
concentration rose significantly at early times but returned to pretreatment levels by 10 
minutes. Figure 5A,B show that the total glutathione pool was mostly reduced in 
hepatocytes. Cysteine-glutathione disulfide (Figure 5A, bottom curve) was not as great a 
factor in determining the disulHde bonding state of the glutathione pool (Figure 5A, top 
curve) as it was in NIH-3T3 cells (Figure 3A.). It did have different kinetics of formation 
from GSSG (Figure 5A, middle curve) or S-nitrosoglutathione (Figure 5B, bottom curve). S-
nitrosoglutathione accounted for slightly less than 50% of the total oxidized glutathione 
(Figure SB top curve) and was the most abundant oxidized form of glutathione in 
Figure 4. Effect of S-nitrosocysteine on low molecular weight thiols in rat primary 
hepatocytes. 
A. Cultured primary hepatocytes were prepared according to established protocols 
(34) and treated with I mM S-nitrosocysteine for the indicated times. Low molecular weight 
thiols were analyzed in cellular lysates by anion exchange HPLC as described in Materials 
and Methods. Cystine could not be resolved in hepatocyte lysates. Non-standard 
abbreviations: GSNO, S-nitrosoglutathione; CSSG, cysteine-glutathione disulfide. B. Time 
dependent changes in total glutathione (GSSG + cysteine-glutathione disulfide + S-
nitrosoglutathione + GSH) and total cysteine (cysteine-glutathione disulfide +cysteine) 
calculated fi'om data obtained in part A of this figure. 
Total Glutathione 
(nmol/mg protein) 
OJ ON vo tsl 
o o o o o o 
n o 
^ E 
O p— — K) to O o 
Total Cysteine 
(nmol/mg protein) 
Concentration (nmol/mg protein) 
to OJ ^ 
o o o o o 
H ^ ^ ^  - J  
r 
• • 0 • 
o o n o o C/3 C/5 c/a v: in C/3 m in U) 7, O O 2. 5' 
n 
O 
Figure 5. Time dependent clianges in fraction of oxidized glutathione with S-
nitrosocysteine addition in primary hepatocytes. 
The fractions of oxidized glutathione in hepatocytes after S-nitrosocysteine addition 
were calculated from data in Figure 4A. Non-standard abbreviations: GSNO, S-
nitrosoglutathione; CSSG, cysteine-glutathione disulHde. A. Time dependent changes in 
disulfide formation of glutathione with S-nitrosocysteine addition. B. Time dependent 
changes in oxidation, including S-nitrosylation, of glutathione. 
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hepatocytes. 
Overall, the low molecular weight thiol pool returned to normal before 30 minutes after 
addition of S-nitrosocysteine to hepatocyte cultures. This data suggests that effects of S-
nitrosocysteine on cellular thiols can vary quantitatively with cell type, but the phenomena of 
S-nitrosylation and oxidation of intracellular thiols remains qualitatively the same. The 
much greater concentration of GSH in these cells probably played a large role in 
counteracting effects of S-nitrosocysteine. 
Effect of S-nitrosoglutathione and S-nitroso-N-acetylpenicillamine on NIH-3T3 cells. 
S-nitrosoglutathione and S-nitroso-N-acetylpenicillamine are S-nitrosothiols that act as 
vasodilators in vivo (12,18). Like S-nitrosocysteine, they are commonly used to deliver NO 
in a variety of experiments (3,9,12). Intracellular effects of these two S-nitrosothiols on low 
molecular weight thiols were therefore assessed for comparison to the effects of S-
nitrosocysteine. 
Incubation of cells with 0.1 mM S-nitrosoglutathione produced no measurable changes in 
intracellular low molecular weight thiols (Table 11). Increasing S-nitrosoglutathione to 1.0 
mM did cause some increases in intracellular S-nitrosoglutathione, but did not change GSH 
(Table II), cystine, cysteine or cysteine-glutathione disulfide (not shown). Treatment with 10 
mM S-nitrosoglutathione caused a dramatic increase in intracellular S-nitrosoglutathione and 
significantly depleted GSH. Only 10 mM S-nitrosoglutathione treatment caused a signiHcant 
increase in the fraction of oxidized glutathione. Both S-nitrosoglutathione and GSSG levels 
were much greater than GSH levels after 30 minutes. This indicates that the cells were 
unable to e^ectively metabolize S-nitrosoglutathione at 10 mM despite only slight changes 
associated with 1 mM S-nitrosoglutathione treatment. Whether this is because of loss 
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Table II 
Effect of S-nitrosoglutathione and S-nitroso-N-
acetylpenicillamine on low molecular weight thiols in NIH-
3T3 ceUs. 
S-nitrosoglutathione (GSNO) or S-nitroso-N-
acetylpenicillamine (SNAP) was added to NIH-3T3 cell 
cultures in the indicated concentrations and low molecular 
weight thiols were analyzed by anion exchange HPLC as 
described in Materials and Methods. Cysteine, cysteine 
glutathione disulfide and cystine concentrations were 
unchanged (not shown). Data are reported in units of 
nmol/mg total protein. 
Treat. Cone. time GSNO GSH GSSG 
(mM) (min) (nmoI/mg) (nmol/mg) (nmol/mg) 
GSNO — 0 0.50±0.04 14±1 0.45±0.09 
0.1 10 0.4±0.1 11±2 0.32±0.03 
30 0,41±0.05 12±1 0.42±0.05 
60 0.5±0.2 15±0 0.35±0.06 
1 10 0.90±0.02 12±3 0.4±0.1 
30 1.4±0.1 15±0 0.49±0.03 
60 1.3±0.2 12±1 0.47±0.07 
10 10 11±4 8.7±0.1 1.3±0.3 
30 23±1 0.5±0.3 2.5±0.9 
60 40±30 0.1±0.2 5±3 
SNAP — 0 0.12±0.03 20±3 0.25*0.03 
I 10 0.24±0.09 21±5 0.30±0.09 
30 0.29±0.08 17±4 0.28*0.02 
60 0.5±0.2 14±1 0.22±0.03 
10 10 2.1±0.4 13±1 0.21±0.03 
30 2.8±0.5 8±2 0.19±0.02 
60 2.6±0.3 13±2 0.20±0.01 
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of cellular integrity or through some other mechanism was not explored. S-
niurosoglutathione caused increases in intracellular S-nitrosoglutathione much more slowly 
than did S-nitrosocysteine. This suggests that S-nitrosoglutathione does not enter the cell as 
readily as S-nitrosocysteine, and that significant amounts of S-nitrosoglutathione remained 
outside of the cells for at least 30 minutes. 
S-nitroso-N-acetylpenicillamine (0.1 mM) caused no measurable changes in either 
GSH or S-nitrosoglutathione (not shown). Addition of ImM S-nitroso-N-acetylpenicillamine 
caused a much smaller increase in intracellular S-nitrosoglutathione (Table II) than did 
treatment with I mM S-nitrosocysteine (Table I). Increasing S-nitroso-N-acetylpenicillamine 
concentration to 10 mM produced significant S-nitrosylation of GSH. Both 1 and 10 mM S-
nitroso-N-acetylpenicillamine caused depletion of the GSH pool over time. While the 
fraction of glutathione in the form of GSSG did not change at any concentration, S-
nitrosoglutathione accounted for a significant portion of the total glutathione at 10 mM S-
niu:oso-N-acetylpenicillamine (Table II). S-nitroso-N-acetylpenicillamine caused no 
measurable changes in cystine, cysteine or cysteine-glutathione disulfide at any concentration 
tested (not shown). The effects of S-nitroso-N-acetylpenicillamine in cells were nearly 
maximal after 10 minutes, but were sustained throughout the entire 60 minutes. Overall, 
equal concentrations of S-nitroso-N-acetylpenicillamine had much less effect on low 
molecular weight thiols than either S-nitrosocysteine or S-nitrosoglutathione. 
If I mM cysteine was added to the cell cultures simultaneously with 1 mM S-
nitrosoglutathione, intracellular S-nitrosoglutathione, cysteine, cystine and cysteine-
glutathione disulfide increased rapidly (Figure 6). This effect was similar to 1 mM S-
nitrosocysteine alone. L-cysteine or D-cysteine were both effective. This suggests that 
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PBS GSNO S-nitroso- GSNO+ GSNO + 
cysteine l-Cys d-Cys 
0 Cystine 
I GSNO 
;„j 0 Cysteine 
SCSSG 
• GSH 
IGSSG 
Figure 6. Comparison of S-nitrosoglutathione, S-nitrosocysteine or S-
nitrosoglutathione/cysteine effects on low molecular weight thiols. 
NIH-3T3 cells were treated with 1 mM S-nitrosoglutathione, 1 mM 
S-nitrosocysteine, 1 mM S-nitrosoglutathione + 1 mM L-cysteine, or 1 mM 
S-nitrosogiutathione + 1 mM D-cysteine for 10 minutes. Low molecular weight thiols 
were analyzed by anion exchange HPLC as described in Materials and Methods. Non­
standard abbreviations: GSNO, S-nitrosoglutathione; CSSG, cysteine-glutathione 
disulfide. 
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S-nitrosoglutathione is S-nitrosylating cysteine, which then enters the cells and causes 
changes in the low molecular weight thiol pool. While intracellular S-nitrosoglutathione and 
cysteine-glutathione disulfide levels of S-nitrosocysteine-treated and S-
nitrosoglutathione/cysteine-treated cells were similar, GSH was less depleted and cysteine 
increased more in the S-nitrosoglutathione/cysteine-treated cells. These differences may 
have been caused by fi*ee cysteine entering the cell, supplementing the intracellular cysteine 
pool and protecting the GSH pool from oxidation. Neither the increase in S-
nitrosoglutathione nor the increases in cystine or cysteine-glutathione disulfide could be 
accounted for by reduced cysteine entering the cell. 
S-nitrosylation and S-thiolation of soluble proteins in NIH-3T3 cells by S-nitrosocysteine. 
The biological effects of S-nitrosothiols may be caused by S-nitrosylation of protein thiols in 
cells (7,10,35). However, the effect of S-nitrosocysteine on low molecular weight thiols 
suggests both S-nitrosylation and S-thiolation of protein thiols might be important. S-
thiolation and S-nitrosylation of protein thiols can be studied readily by methods already 
developed. Proteins are isolated by methods that block artifactual modification of cysteine 
(21). S-thiolation is measured by release of thiols by reduction (29), while S-nitrosylation is 
measured as mercuric chloride releasable nitrite (31). To test stability of S-nitrosylated 
proteins during dialysis, standards of reduced and S-nitrosylated phosphorylase b were 
prepared as previously described by Ji, et. al. (6). S-nitrosylation is assayed by inhibition 
iodoacetic acid allcylation as determined by isoelectric focusing (lEF) analysis (Figure 7). 
lEF separates proteins based on their net charge. For each alkylated cysteine on 
phosphorylase b, the protein migrates at a progressively more acidic pi. Phosphorylase b 
possesses four cysteine residues that react with iodoacetic acid (lane I). lEF shows that most 
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4 days 5 days 
Fully S-nitrosylated 
c 
Partially S-nitrosylated 
Fully Reduced ^ 
lAA GSNO lAA 
+ + 
lAA GSNO 
lAA GSNO lAA 
+ + 
lAA GSNO 
lAA GSNO lAA 
+ + 
lAA GSNO 
lane 1 8 
Figure 7. Stability of S-nitrosylated phosphorylase b with dialysis. 
Phosphorylase b was incubated with iodoacetic acid (lAA) (lanes 1,4,7), S-
nitrosoglutathione (S-nitrosoglutathione) followed by lAA (lanes2,5,8), or lAA followed 
by S-nitrosoglutathione (lanes3,6,9). S-nitrosoglutathione treatment was a 15 minute 
incubation at pH 7.4 and 37°C. Phosphorylase b was alkylated by a 20 minute 
incubation at 37°C with 40 mM lAA at pH 8,0. Samples were dialyzed to remove excess 
S-nitrosoglutathione for 4 or 5 days before the nitrite assay. Replicate samples were 
separated on lEF. S-nitrosylated and reduced phosphorylase b were identiHed as 
described (6). Bands marked "c" denote a contaminant protein in the preparation (36) 
that is removed upon dialysis. 
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of the protein is fiilly S-nitrosylated after S-nitrosoglutathione treatment, with some partially 
S-nitrosylated species evident (lane 2). If phosphorylase b is alkylated before S-
nitrosoglutathione treatment, S-nitrosylation is prevented (lane 3). After 4 (lanes 4-6) or 5 
(lanes 7-9) days dialysis, the distribution of bands between the fully S-nitrosylated and 
partially S-nitrosylated forms (compare lanes 2, S, and 8) remains constant. The lEF data 
therefore shows that the protein was stable during dialysis. After 4 or 5 days of dialysis, 3.4 
mols of S-nitrosothiol per mol phosphorylase b were found as determined by the nitrite 
assay. Analysis of soluble protein S-nitrosothiols firom NIH-3T3 cell extracts showed similar 
recoveries from samples dialyzed 4 days compared to those dialyzed for 5 days (not shown). 
The icinetics of protein S-nitrosylation, S-glutathiolation, and S-cysteylation initiated 
by 1 mM S-nitrosocysteine were similar to those of the low molecular weight thiol pool 
(Figure 8A), peaking at 3 minutes and decreasing thereafter. S-nitrosylation was more than 
10 times greater than S-glutathiolation or S-cysteylation. This decreased to about S times 
greater by 10 minutes. Figure SB shows the concentration dependence of protein cysteine 
modification by S-nitrosocysteine. Slight increases of S-cysteylated and S-nitrosylated, but 
not S-glutathiolated proteins, occurred with 0,1 mM S-nitrosocysteine. Proteins were heavily 
S-nitrosylated after treatment by 10 mM S-nitrosocysteine and S-cysteylation became more 
prominent. While GSH was depleted after 10 mM S-nitrosocysteine treatments, protein 
sulfhydryls were not. 
S-nitrosylation and S-glutathiolation ofH-Ras in NIH-3T3 cells. Since S-
nitrosocysteine was effective in causing S-nitrosylation, and, to a lesser extent, S-thiolation 
of protein thiols, we examined whether modiHcation of H-Ras would also follow this pattern 
or whether specific proteins or specific cysteines would react differently. In order to study 
Figure 8. Total soluble protein S-cysteylation, S-glutathiolation, and S-nitrosylation of 
NIH-3T3 cells with S-nitrosocysteine addition. 
A. Time course of protein cysteine modification with ImM S-nitrosocysteine. Cells 
were incubated with 1 mM S-nitrosocysteine for the indicated times and lysed with 10 mM 
^-glycerophosphate buffer containing 50 mM N-ethylmaleimide. Total soluble protein S-
glutathiolation or S-cysteylation was measured by trichloroacetic acid precipitation of soluble 
proteins followed by anion exchange HPLC of low molecular weight thiols released by DTT 
as described in Materials and Methods. Total protein S-nitrosylation was measured by nitrite 
assay of dialyzed cellular lysates as described in Materials and Methods. B. Concentration 
dependence of total soluble protein cysteine modiHcation with 10 minute treatments with 
indicated concentrations of S-nitrosocysteine. Samples were processed as in part A. 
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H-Ras in vivo, it was necessary to utilize cells that overexpressed H-Ras, Figure 9A shows 
effects of S-nitrosocysteine on low molecular weight thiols in NIH-3T3 cells overexpressing 
the wildtype H-Ras protein (NIH-3T3/WT). Since overexpression of H-Ras can have 
profound effects on the cellular morphology and metabolism (37), and possibly may also 
affect cellular response to S-nitrosocysteine treatment, it was important to establish the effect 
of S-nitrosocysteine on these cells. In spite of the fact that NIH-3T3/WT cells grew to a 
population that contained many more cells and approximately three times the total protein of 
the normal NIH-3T3 cells, the GSH concentration was similar to that of the parental NIH-
3T3 cells. As in normal NIH-3T3 cells, S-nitrosocysteine caused rapid increases in S-
nitrosoglutathione, cysteine, cystine and cysteine-glutathione disulfide and caused decreases 
in GSH. There are also rapid increases in S-nitrosylation, S-cysteylation, and S-
glutathiolation of cytosolic proteins (Figure 9B). By these measures, overexpression of H-
Ras does not significantly affect cellular responses to S-nitrosocysteine. 
H-Ras was immunoprecipitated from these cells and the effect of S-nitrosocysteine 
was examined by methods described in the figure legend. Figure lOA shows that the 
immunoprecipitate contained primarily H-Ras. When the NO was determined on these 
immunoprecipitates, there was no evidence of S-nitrosylation of H-Ras in untreated cells, 
while in S-nitrosocysteine-treated cells, 43 nmols of S-nitrosothiol were detected per mg H-
Ras (Figure lOB). This is equivalent to 0.8S moles S-nitrosothiol per mole of H-Ras in cells 
after S-nitrosocysteine treatment. H-Ras contained 43 nmol S-NO/mg of protein, as 
compared to 15 nmol S-NO/mg for the total cytosolic protein. Thus, H-Ras may be more 
Figure 9. Thiol modification in NIH-3T3 cells overexpressing the H-Ras wildtype 
protein with S-nitrosocysteine addition. 
A. Analysis of low molecular weight thiols upon addition of 1 mM S-nitrosocysteine 
for the indicated times. Thiols were quantified using anion exchange HPLC as described in 
Materials and Methods. Non-standard abbreviations: GSNO, S-nitrosoglutathione; CSSG, 
cysteine-glutathione disulfide. B. Total soluble protein S-cysteylation, S-glutathiolation and 
S-nitrosylation with addition of S-nitrosocysteine. Cells were treated with I mM S-
nitrosocysteine for the indicated times and then lysed with lOmM 3-glycerophosphate buffer 
containing 50 mM N-ethylmaleimide. Protein S-thiolation was measured by TCA 
precipitation of cytoplasmic proteins followed by anion exchange HPLC of DTT-releasabie 
low molecular weight thiols as described in Materials and Methods. Protein S-nitrosylation 
was measured by nitrite assay of dialyzed soluble proteins as described in Materials and 
Methods. 
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Figure 10. S-Nitrosyiation of H-Ras in NIH-3T3AyT cells with S-nitrosocysteine 
addition. 
A. NIH-3T3 cells (lane 1) or NIH-3T3/WT cells (lanes 2 and 3) were incubated with 
PBS (lanes 1 and 2) or with 1 mM S-nitrosocysteine for 3 nunutes (lane 3), Cells were 
washed twice with PBS and lysed with detergent-containing immunoprecipitation buffer + 
50mM NEM. H-Ras protein was then iniinunoprecipitated from the extracts as described in 
Materials and Methods. One extra wash with PBS was added in order to remove detergents, 
which were found to interfere with the nitrite assay. The H-Ras bound to agarose beads was 
then analyzed for NO with the nitrite assay as described in Materials and Methods. Two 
samples of each immunoprecipitation were determined. An aliquot of each experimental 
treatment was separated by SDS-PAGE as described (32) and the protein content of each 
assay was calculated from the SDS-PAGE by comparison with a dilution series of purified 
H-Ras on the same gel (not shown). B. Analysis of S-nitrosylated H-Ras. H-Ras was 
immunoprecipitated from NIH/3T3 cells and S-nitrosylation of the immunoprecipitated 
protein was determined by nitrite release as described in part A of this figure. Duplicate 
samples of each treatment are shown. The protein content of each lane was determined as 
described in part A of this figure to normalize the NO content of each immunoprecipitate for 
the amount of H-Ras. 
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sensitive to S-nitrosylation than the average cytosolic protein in cells. 
To measure S-thiolation of H-Ras in these cells, the glutathione was labeled with ^^S-
cysteine. After 24 hour labeling, the specific activity of GSH and cysteine was 6.5 x 10^ 
cpm/^mol while GSSG and cysteine-glutathione disulHde were twice that (1.8 x 10® 
cpm/|xmoI) as is expected (Figure 11 A). The S-glutathiolation of H-Ras was determined by 
assaying protein-bound radioactivity. Figure 1 IB shows that approximately 8 nmols of GSH 
were covalently bound to each mg of H-Ras upon S-nitrosocysteine treatment, or 
approximately 0.16 moles per mole of H-Ras. When compared to the 1.6 nmols/mg S-
glutathiolation of total cytosolic proteins, this suggests that H-Ras is more readily S-
glutathiolated than the average cytosolic protein. 
The specific activity of GSH and GSSG was unchanged during the course of the 
experiment (Figure 11 A), suggesting that the cysteine moiety of S-nitrosocysteine was not 
being used to synthesize GSH during this experiment. The specific activity of cysteine 
decreased 30-fold to 2.2 x 10^ cpm/^imol. The speciHc activity of cysteine-glutathione 
disulfide became identical to that of GSH after 3 minutes because the radioactivity associated 
with cysteine was insignificant in comparison to that of glutathione. The specific activity of 
cysteine did not change after the initial drop at 3 minutes. Thus, S-nitrosocysteine was 
completely equilibrated with the cysteine pool before the 3 minute time point. 
Discussion 
S-nitrosocysteine appears to be an S-nitrosothiol with unique properties. Our data 
support the idea that that the entire S-nitrosocysteine molecule enters the cell and reacts with 
Figure 11. S-glutathiolation of H-Ras in NIH-3T3AVT cells with S-nitrosocysteine 
addition. 
A. NIH-3T3 cells overexpressing WT H-Ras were incubated with Tran^^S-label for 
24 hours and after 5 minute PBS incubation, were treated with ImM S-nitrosocysteine. At 
the indicated times, cells were washed twice with ice cold PBS, lysed with 10% PCA and 
derivatized for low molecular weight thiol analysis as described in Materials and Methods. 
SpeciHc activity was obtained as described in Materials and Methods. All data points were 
determined in duplicate. Non-standard abbreviation: CSSG, cysteine-glutathione disulfide. 
B. NIH-3T3AVT cells were labeled with Tran"S-Iabel for 24 hours and subsequently treated 
with PBS or ImM S-nitrosocysteine for 3 minutes. Cells were washed twice with ice cold 
PBS and then lysed with detergent containing immunoprecipitation buffer + 50mM NEM. 
H-Ras was then immunoprecipitated from the extracts and S-glutathiolated H-Ras was 
determined as described in Materials and Methods. The bar graph shows the data obtained 
from duplicate immunoprecipitations. 
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GSH and protein thiols. The decrease of specific activity of cysteine after addition of 
unlabeled S-nitrosocysteine to cells with an ^^S-labelled cysteine pool (Figure 1 lA) shows 
that cysteine from added S-nitrosocysteine is entering the cells. The specific activity of the 
cysteine pool does not change after 3 minutes, which means that the cysteine pool is 
equilibrated with the cysteine from S-nitrosocysteine by this time. The increase in S-
nitrosoglutathione, cysteine, S-nitrosylated proteins, S-glutathiolated proteins, and S-
cysteylated proteins, and the decrease in GSH all reached their maximum levels within 3 
minutes. This suggests that the nitrosative and oxidative effects of S-nitrosocysteine addition 
to cells are dependent on the uptake of S-nitrosocysteine from the extracellular space. The 
increase in total cysteine as calculated by total decrease in specific activity of cysteine pool 
and the total increase in S-nitrosothiols (S-nitrosoglutathione + protein S-nitrosothiols) 
indicate that greater than 90% of total cysteine increase is accounted for by S-nitrosothiol 
increase. In other words, it appears that the assays presented here account for most of the S-
nitrosocysteine entering the cell. Both nitrosyiation and oxidation can therefore be 
considered primary events that result from uptake of S-nitrosothiols into cells. 
Related compounds, S-nitrosoglutathione and S-nitroso-N-acetylpenicillamine are, on 
an equimolar basis, less effective oxidants and NO donors. Addition of cysteine to medium 
with S-nitrosoglutathione causes effects similar to addition of S-nitrosocysteine. Either D- or 
L-cysteine can mediate these effects. This suggests that S-nitrosocysteine is being taken into 
the cell at least partly via a non-stereospecific mechanism. Others have suggested that S-
nitroso-D-cysteine may not taken up in cells as well as S-nitroso-L-cysteine (9,38). This may 
be a cell-speciHc phenomenon. Overall, data presented here agree with the hypothesis of a 
membrane transport role for S-nitrosocysteine postulated in previous reports (20). 
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While the S-nitrosylation of protein thiols was the dominant modification in response 
to nitrosative stress, a signiHcant amount of protein S-thiolation was observed. The 
consequences of S-nitrosylation and S-thiolation on a protein might be similar if thiol 
modification inhibits the active site of a protein, as in the case of caspase (10), protein 
tyrosine phosphatase (39) or glyceraldehyde-3-phosphate dehydrogenase (GADPH) (19). 
However, it is more likely that allosteric effects, as suggested for H-Ras (7), would be 
mediated through addition of a large molecule carrying multiple charges such as glutathione, 
than a small, uncharged molecule like NO. Therefore, differentiating between these two 
modifications in vivo may be crucial to understanding the effects of S-nitrosothiol addition to 
cells. 
Reports have been published about nitrosative and oxidative regulation of many 
diverse cellular functions (10,40,41). Among these are studies showing that the Erk pathway 
is upregulated in response to exposure of cells to diverse oxidative and nitrosative events (2-
7). Several proteins along this pathway have been targeted for study with respect to this 
regulation (3,4,5,42). Among these proteins, the low molecular weight GTPase H-Ras was 
implicated by protein modification in vitro (43) and by mutational analysis in vivo (7). In 
vitro results in our lab suggested that H-Ras could be S-nitrosylated on as many as four sites 
(6,see Chapter II), while it could be S-glutathiolated on two sites (see Chapter II). Other labs 
have also shown that H-Ras is S-nitrosylated on at least one site in vitro (43). Within cells 
after treatment with S-nitrosocysteine, H-Ras is S-nitrosylated and S-glutathiolated to an 
equal or greater extent than the cytosolic protein pool (Figures 10 and 11). H-Ras is 
therefore a candidate for modulation of Erk pathway activity under oxidative/nitrosative 
conditions. It remains to be determined which sites are modified and what the effects of 
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modification are in vivo. Data in other labs indicates that S-nitrosylation of CysllS of H-Ras 
would activate the Erk pathway. However, the fact that multiple cysteine residues, including 
the c-terrainal cysteine residues that are normally lipidated, can be readily S-nitrosylated in 
vitro (6, see Chapter II) and S-thiolated in vitro and in vivo (see Chapter II) suggests that 
modulation of this pathway by H-Ras would be heavily dependent upon the source and dose 
of the oxidant stimulus in question. 
In conclusion, this supports the idea that nitrosative modification of H-Ras occurs in 
vivo. It is the first report of S-glutathioIation in vivo of a specific protein in response to what 
was previously thought to be a nitrosative stimulus. This represents a first step in elucidating 
the primary events associated with initiation of redox regulation of signal transduction events 
in vivo. 
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GENERAL SUMMARY AND CONCLUSIONS 
Mechanism of antioxidant and regulatory properties of GSH 
This dissertation provides evidence that GSH protects carbonic anhydrase III from 
irreversible damage by H2O2 or peroxyradicals. This extends the understanding of GSH-
mediated protection of protein cysteines. It defines the concentrations at which GSH acts as 
an S-glutathioIating agent in concert with protein cysteines as opposed to a scavenger that 
does not interact with proteins. The concentration of GSH in cells is likely to be close to 
equimolar to the concentration of protein sulfhydryls. The data in chapter I show that S-
glutathiolation is likely to occur at these GSH to protein ratios. This suggests that S-
glutathiolation is at least as important for protection of proteins from damage, and is likely to 
be more important, than is direct scavenging of reactive oxygen species by GSH. The greater 
reactivity of H2O2 with H-Ras, in comparison to GSH (chapter II), while not conclusive in 
and of itself, agrees with this assessment. 
GSH participates in oxidative modifications of protein cysteines at molar ratios of 
GSH:protein cysteine that are physiologically relevant. The role of GSH in protein oxidation 
is not merely that of a scavenger of oxyradicals as is widely believed, but as a co-participant 
in a fast, two step reaction between proteins, GSH and an oxidant. This means that in order 
for S-glutathiolation to occur, it is not necessary for GSSG to form. Thus, protein diiols may 
be oxidized before GSH is oxidized to GSSG. In this case, GSH converts the oxidized 
reactive protein thiol to the mixed disulfide. This prevents further oxidation of the protein 
thiol to irreversibly oxidized forms of cysteine and may have other implications. 
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S-glutathiolation and oxidation of H-Ras 
H-Ras is believed to participate in relaying oxidative signals through the Erk pathway 
(52-57). Because the oxidants which had been shown to activate this pathway, H2O2, 
superoxide, the peroxynitrite donor, 3-morpholinosydnonimine (SIN-1), NO, S-nitroso-N-
acetylpenicillamine, and sodium nitroprusside, all react readily with cysteine, cysteine 
oxidation might mediate this effect. One group of workers showed the modification of a 
truncated mutant of H-Ras with NO in vitro (56). This data, along with the activation of Erk 
in Jurkat T cells by NO led them to suggest that H-Ras was allosterically activated by S-
nitrosylation of Cysl 18 in vivo. While this explanation was plausible, there remained no 
evidence of modification of H-Ras in vivo under oxidative or nitrosative conditions. 
Chapters II and III of this dissertation show diat H-Ras, a critical protein component of the 
Erk signal transduction cascades, is modified both oxidatively and nitrosatively both in vitro 
and in vivo. This modification takes place on multiple thiols in vitro and the same is likely in 
vivo. This work presents evidence that H-Ras is readily modified on multiple thiols by 
several thiol oxidants, H2O2, S-nitrosoglutathione, GSSG, cystamine, and diamide in vitro. 
We also show that H-Ras is S-thiolated in cells by the thiol oxidant diamide. This 
oxidation takes place on at least one of the cysteines which is normally lipidated, as indicated 
by the data that H-Ras lacking Cysl 18 is still S-thiolated. While oxidation of Cysl 18 may 
occur and activate H-Ras, oxidation of cysteines 181,184 or 186 may also occur and 
inactivate H-Ras (48,49,56). This provides a plausible mechanism for both activation and 
inactivation of H-Ras by a single oxidant. This mechanism is of course dependent upon 
concentration of oxidant and the reactivity of individual cysteine residues. In vivo, this 
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modiflcation would also be subject to the availability of cysteine residues, which may be 
limited by lipid modification. 
Chapter III shows that H-Ras is S-nitrosylated in cells treated with S-nitrosocysteine. 
In agreement with in vitro data showing that H-Ras is somewhat more reactive than GSH 
towards H2O2 (Chapter II), H-Ras appears to be S-nitrosylated to a similar or greater extent 
than the average cytosolic protein (Chapter III). H-Ras is also S-glutathiolated in cells 
treated with S-nitrosocysteine. In this case, H-Ras seems to be significantly more S-
glutathiolated than the average cytosolic protein (Chapter III). 
Cell-type speciflc changes in response to oxidation 
It is necessary to know the oxidation state of thiols in the cell to better predict 
mechanisms for activation or inactivation of a particular protein or pathway by an oxidant. 
The differences between response of a pathway, as is observed between different cell lines in 
Erk activation with oxidative and nitrosative stress (54), may be a result of the ability of a 
particular cell line to deal with a given stress. This is illustrated most simply in Chapter III in 
the difference in response of the primary hepatocytes to S-nitrosocysteine treatment when 
compared to the response of NIH-3T3 cells. The response to different concentrations of 
diamide was also altered depending on which H-Ras mutant was overexpressed in the cells 
(Chapter II). While the overexpression of H-Ras in NIH-3T3 cells did not seem to 
significantly affect the oxidative treatment with 1 mM S-nitrosocysteine at early time points 
(Chapter m), the response may have varied at different concentrations, and the recovery of 
the cell at later time points may have been altered. 
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Oxidative modulation of Erk pathway activity 
The Erk pathway may be activated by modi^cation of H-Ras but it may also be 
inactivated (48,49,53). While this study shows that by all criteria examined that H-Ras is 
readily modified in oxidative conditions, there are several other members of the Erk pathway 
that may be regulated by cysteine oxidation. For example, protein tyrosine phosphatases 
have been shown to be inhibited by S-glutathiolation and formation of protein cysteine 
sulfenic acids (14,34,35). Oxidation a tyrosine phosphatase may directly modify the 
phosphorylation state of the Erk proteins. The Raf proteins also contain cysteine-rich regions 
that are required for activity. Disruption of these regions by oxidation may be a mechanism 
for inactivation of the Erk pathway. Thus, a more quantitative assessment of oxidative 
effects on all of the proteins in the Erk pathway is necessary before one can determine the 
importance of modification of any one protein. 
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